Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.
A pathological process consisting of the formation of new blood vessels in the CHOROID.
Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium.
The single layer of pigment-containing epithelial cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial cells are macroglia that perform essential functions for the photoreceptor cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinal attachment.
A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
An important soluble regulator of the alternative pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex (COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY).
The inner layer of CHOROID, also called the lamina basalis choroideae, located adjacent to the RETINAL PIGMENT EPITHELIUM; (RPE) of the EYE. It is a membrane composed of the basement membranes of the choriocapillaris ENDOTHELIUM and that of the RPE. The membrane stops at the OPTIC NERVE, as does the RPE.
The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye.
The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)
A naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age.
Optic disk bodies composed primarily of acid mucopolysaccharides that may produce pseudopapilledema (elevation of the optic disk without associated INTRACRANIAL HYPERTENSION) and visual field deficits. Drusen may also occur in the retina (see RETINAL DRUSEN). (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p355)
The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.
An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.
Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.
A xanthophyll found in the major LIGHT-HARVESTING PROTEIN COMPLEXES of plants. Dietary lutein accumulates in the MACULA LUTEA.
An area approximately 1.5 millimeters in diameter within the macula lutea where the retina thins out greatly because of the oblique shifting of all layers except the pigment epithelium layer. It includes the sloping walls of the fovea (clivus) and contains a few rods in its periphery. In its center (foveola) are the cones most adapted to yield high visual acuity, each cone being connected to only one ganglion cell. (Cline et al., Dictionary of Visual Science, 4th ed)
Specialized PHOTOTRANSDUCTION neurons in the vertebrates, such as the RETINAL ROD CELLS and the RETINAL CONE CELLS. Non-visual photoreceptor neurons have been reported in the deep brain, the PINEAL GLAND and organs of the circadian system.
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.
Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
Recording of electric potentials in the retina after stimulation by light.
Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
Therapy using oral or topical photosensitizing agents with subsequent exposure to light.
'Eye proteins' are structural or functional proteins, such as crystallins, opsins, and collagens, located in various parts of the eye, including the cornea, lens, retina, and aqueous humor, that contribute to maintaining transparency, refractive power, phototransduction, and overall integrity of the visual system.
Degenerative changes in the INTERVERTEBRAL DISC due to aging or structural damage, especially to the vertebral end-plates.
Examination of the interior of the eye with an ophthalmoscope.
Oxygenated forms of carotenoids. They are usually derived from alpha and beta carotene.
An exudate between the RETINA and CHOROID from various sources including the vitreous cavity, SUBARACHNOID SPACE, or abnormal vessels.
Method of making images on a sensitized surface by exposure to light or other radiant energy.
A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions.
Retinal diseases refer to a diverse group of vision-threatening disorders that affect the retina's structure and function, including age-related macular degeneration, diabetic retinopathy, retinal detachment, retinitis pigmentosa, and macular edema, among others.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
Diseases affecting the eye.
Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
Bleeding from the vessels of the retina.
Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132).
Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.).
A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb.
A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.
A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.
The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
A series of tests used to assess various functions of the eyes.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.
A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).
Hereditary, progressive degeneration of the neuroepithelium of the retina characterized by night blindness and progressive contraction of the visual field.
Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.
Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.
Photosensitive protein complexes of varied light absorption properties which are expressed in the PHOTORECEPTOR CELLS. They are OPSINS conjugated with VITAMIN A-based chromophores. Chromophores capture photons of light, leading to the activation of opsins and a biochemical cascade that ultimately excites the photoreceptor cells.
A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
The coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed)
The light sensitive outer portion of a retinal rod or a cone photoreceptor cell. The outer segment contains a stack of disk membranes laden with photoreceptive pigments (RETINAL PIGMENTS). The outer segment is connected to the inner segment by a PHOTORECEPTOR CONNECTING CILIUM.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
Centers for storing various parts of the eye for future use.
Color of the iris.
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
The administration of substances into the eye with a hypodermic syringe.
Pyridinium compounds are organic salts formed when pyridine, a basic heterocyclic organic compound, reacts with acids, resulting in a positively charged nitrogen atom surrounded by aromatic rings.
Method of measuring and mapping the scope of vision, from central to peripheral of each eye.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Methods and procedures for the diagnosis of diseases of the eye or of vision disorders.
The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.
Specialized cells that detect and transduce light. They are classified into two types based on their light reception structure, the ciliary photoreceptors and the rhabdomeric photoreceptors with MICROVILLI. Ciliary photoreceptor cells use OPSINS that activate a PHOSPHODIESTERASE phosphodiesterase cascade. Rhabdomeric photoreceptor cells use opsins that activate a PHOSPHOLIPASE C cascade.
Any of the 23 plates of fibrocartilage found between the bodies of adjacent VERTEBRAE.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
The blood vessels which supply and drain the RETINA.
A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase.
The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX.
Photosensitive afferent neurons located primarily within the FOVEA CENTRALIS of the MACULA LUTEA. There are three major types of cone cells (red, blue, and green) whose photopigments have different spectral sensitivity curves. Retinal cone cells operate in daylight vision (at photopic intensities) providing color recognition and central visual acuity.
An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum.
A member of the family of tissue inhibitor of metalloproteinases. Mutations of the gene for TIMP3 PROTEIN causes Sorsby fundus dystrophy.
Adjustment of the eyes under conditions of low light. The sensitivity of the eye to light is increased during dark adaptation.
Introduction of substances into the body using a needle and syringe.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
The total area or space visible in a person's peripheral vision with the eye looking straightforward.
A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
Devices that help people with impaired sensory responses.
Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.
The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES.
A plasma serine proteinase that cleaves the alpha-chains of C3b and C4b in the presence of the cofactors COMPLEMENT FACTOR H and C4-binding protein, respectively. It is a 66-kDa glycoprotein that converts C3b to inactivated C3b (iC3b) followed by the release of two fragments, C3c (150-kDa) and C3dg (41-kDa). It was formerly called KAF, C3bINF, or enzyme 3b inactivator.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
'Reading' in a medical context often refers to the act or process of a person interpreting and comprehending written or printed symbols, such as letters or words, for the purpose of deriving information or meaning from them.
A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis.
Pathologic changes that occur in the axon and cell body of a neuron proximal to an axonal lesion. The process is characterized by central chromatolysis which features flattening and displacement of the nucleus, loss of Nissl bodies, and cellular edema. Central chromatolysis primarily occurs in lower motor neurons.
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
Persons with loss of vision such that there is an impact on activities of daily living.
Photosensitive afferent neurons located in the peripheral retina, with their density increases radially away from the FOVEA CENTRALIS. Being much more sensitive to light than the RETINAL CONE CELLS, the rod cells are responsible for twilight vision (at scotopic intensities) as well as peripheral vision, but provide no color discrimination.
Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.
Endogenous proteins that inhibit or inactivate COMPLEMENT C3B. They include COMPLEMENT FACTOR H and COMPLEMENT FACTOR I (C3b/C4b inactivator). They cleave or promote the cleavage of C3b into inactive fragments, and thus are important in the down-regulation of COMPLEMENT ACTIVATION and its cytolytic sequence.
The ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease.
An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range.
Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis.
The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.
A purplish-red, light-sensitive pigment found in RETINAL ROD CELLS of most vertebrates. It is a complex consisting of a molecule of ROD OPSIN and a molecule of 11-cis retinal (RETINALDEHYDE). Rhodopsin exhibits peak absorption wavelength at about 500 nm.
A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
A heterogenous group of degenerative syndromes marked by progressive cerebellar dysfunction either in isolation or combined with other neurologic manifestations. Sporadic and inherited subtypes occur. Inheritance patterns include autosomal dominant, autosomal recessive, and X-linked.
Nonrandom association of linked genes. This is the tendency of the alleles of two separate but already linked loci to be found together more frequently than would be expected by chance alone.
A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)
Type III intermediate filament proteins expressed mainly in neurons of the peripheral and CENTRAL NERVOUS SYSTEMS. Peripherins are implicated in neurite elongation during development and axonal regeneration after injury.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS.
Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports research on the causes, diagnosis, and treatment of diseases of the eye and visual system. It was originally part of the National Institute of Neurological Diseases and Blindness. The National Eye Institute was established in 1968.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
The process in which light signals are transformed by the PHOTORECEPTOR CELLS into electrical signals which can then be transmitted to the brain.
Devices for examining the interior of the eye, permitting the clear visualization of the structures of the eye at any depth. (UMDNS, 1999)
Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.
Enzymes that catalyze the rearrangement of geometry about double bonds. EC 5.2.
Surgery performed on the eye or any of its parts.
A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.
Naturally occurring or synthetic substances that inhibit or retard the oxidation of a substance to which it is added. They counteract the harmful and damaging effects of oxidation in animal tissues.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
A family of MEMBRANE TRANSPORT PROTEINS that require ATP hydrolysis for the transport of substrates across membranes. The protein family derives its name from the ATP-binding domain found on the protein.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Nerve cells of the RETINA in the pathway of transmitting light signals to the CENTRAL NERVOUS SYSTEM. They include the outer layer of PHOTORECEPTOR CELLS, the intermediate layer of RETINAL BIPOLAR CELLS and AMACRINE CELLS, and the internal layer of RETINAL GANGLION CELLS.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
The removal of a cataractous CRYSTALLINE LENS from the eye.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.
A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components (COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9) into the target membrane. The resultant C5b-8-poly-C9 is the "membrane attack complex" or MAC.
whoa, buddy! I'm just a friendly AI and I don't have access to real-time databases or personal data, so I can't provide medical definitions or any other specific information about individuals, places, or things. But I can tell you that I couldn't find any recognized medical definition for "Wisconsin" - it's a state in the United States, not a medical term!
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.
An individual in which both alleles at a given locus are identical.
A carotenoid that is a precursor of VITAMIN A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC). (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Engewood, CO, 1995.)
A serum protein which is important in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. This enzyme cleaves the COMPLEMENT C3B-bound COMPLEMENT FACTOR B to form C3bBb which is ALTERNATIVE PATHWAY C3 CONVERTASE.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits.
Individuals whose ancestral origins are in the southeastern and eastern areas of the Asian continent.
A group of disorders involving predominantly the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the RETINA; RETINAL PIGMENT EPITHELIUM; BRUCH MEMBRANE; CHOROID; or a combination of these tissues.
The inner portion of a retinal rod or a cone photoreceptor cell, situated between the PHOTORECEPTOR CONNECTING CILIUM and the synapse with the adjacent neurons (RETINAL BIPOLAR CELLS; RETINAL HORIZONTAL CELLS). The inner segment contains the cell body, the nucleus, the mitochondria, and apparatus for protein synthesis.
The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation.
That portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
The portion of a retinal rod cell situated between the ROD INNER SEGMENT and the RETINAL PIGMENT EPITHELIUM. It contains a stack of photosensitive disk membranes laden with RHODOPSIN.
Inhaling and exhaling the smoke of burning TOBACCO.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686)

Transplacement mutagenesis: a novel in situ mutagenesis system using phage-plasmid recombination. (1/2258)

Site-specific mutagenesis provides the ability to alter DNA with precision so that the function of any given gene can be more fully understood. Several methods of in vitro mutagenesis are time-consuming and imprecise, requiring the subcloning and sequencing of products. Here we describe a rapid, high fidelity method of in situ mutagenesis in bacteriophage lambda using transplacement. Using this method, mutations are transferred from oligonucleotides to target phages using a plasmid interface. A small (50 bp) homology region bearing a centred point mutation is generated from oligonucleotides and subcloned into a transplacement plasmid bearing positive and negative phage selectable markers. Following a positive/negative selection cycle of integrative recombination and excision, the point mutation is transferred precisely from plasmid to phage in a subset ( approximately 25-50%) of recombinants. As the fidelity of both oligonucleotide synthesis and phage-plasmid recombination is great, this approach is extremely reliable. Using transplacement, point mutations can be accurately deposited within large phage clones and we demonstrate the utility of this technique in the construction of gene targeting vectors in bacteriophages.  (+info)

Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. (2/2258)

In a prospective cohort study, the authors examined whether self-selection for antioxidant vitamin supplement use affects the incidence of age-related maculopathy. The study population consisted of 21,120 US male physician participants in the Physicians' Health Study I who did not have a diagnosis of age-related maculopathy at baseline (1982). During an average of 12.5 person-years of follow-up, a total of 279 incident cases of age-related maculopathy with vision loss to 20/30 or worse were confirmed by medical record review. In multivariate analysis, as compared with nonusers of supplements, persons who used vitamin E supplements had a possible but nonsignificant 13% reduced risk of age-related maculopathy (relative risk = 0.87, 95 percent confidence interval (CI) 0.53-1.43), while users of multivitamins had a possible but nonsignificant 10% reduced risk (relative risk = 0.90, 95% CI 0.68-1.19). Users of vitamin C supplements had a relative risk of 1.03 (95% CI 0.71-1.50). These observational data suggest that among persons who self-select for supplemental use of antioxidant vitamin C or E or multivitamins, large reductions in the risk of age-related maculopathy are unlikely. Randomized trial data are accumulating to enable reliable detection of the existence of more plausible small-to-moderate benefits of these agents alone and in combination on age-related maculopathy.  (+info)

Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. (3/2258)

Many substrates for P-glycoprotein, an ABC transporter that mediates multidrug resistance in mammalian cells, have been shown to stimulate its ATPase activity in vitro. In the present study, we used this property as a criterion to search for natural and artificial substrates and/or allosteric regulators of ABCR, the rod photoreceptor-specific ABC transporter responsible for Stargardt disease, an early onset macular degeneration. ABCR was immunoaffinity purified to apparent homogeneity from bovine rod outer segments and reconstituted into liposomes. All-trans-retinal, a candidate ligand, stimulates the ATPase activity of ABCR 3-4-fold, with a half-maximal effect at 10-15 microM. 11-cis- and 13-cis-retinal show similar activity. All-trans-retinal stimulates the ATPase activity of ABCR with Michaelis-Menten behavior indicative of simple noncooperative binding that is associated with a rate-limiting enzyme-substrate intermediate in the pathway of ATP hydrolysis. Among 37 structurally diverse non-retinoid compounds, including nine previously characterized substrates or sensitizers of P-glycoprotein, only four show significant ATPase stimulation when tested at 20 microM. The dose-response curves of these four compounds are indicative of multiple binding sites and/or modes of interaction with ABCR. Two of these compounds, amiodarone and digitonin, can act synergistically with all-trans-retinal, implying that they interact with a site or sites on ABCR different from the one with which all-trans-retinal interacts. Unlike retinal, amiodarone appears to interact with both free and ATP-bound ABCR. Together with clinical observations on Stargardt disease and the localization of ABCR to rod outer segment disc membranes, these data suggest that retinoids, and most likely retinal, are the natural substrates for transport by ABCR in rod outer segments. These observations have significant implications for understanding the visual cycle and the pathogenesis of Stargardt disease and for the identification of compounds that could modify the natural history of Stargardt disease or other retinopathies associated with impaired ABCR function.  (+info)

Central corneal endothelial guttae and age-related macular degeneration: is there an association? (4/2258)

The similarities between the corneal endothelium and retinal pigment epithelium in terms of their embryology, barrier function and predilection to age-related degeneration prompted this investigation into a possible association between central corneal guttae (CCG) and age-related macular degeneration (ARMD). 50 patients with clinically significant CCG were prospectively evaluated for the presence of ARMD. 51 age-matched patients attending for unrelated ailments who did not have CCG were also evaluated for the presence of drusen and other signs of ARMD. Of the 50 patients with CCG, 23 had bilateral ARMD and 4 had unilateral ARMD. In the control group, 9 patients had bilateral and 4 had unilateral ARMD. There was significant difference in the prevalence of ARMD between patients with CCG and those with no CCG (p = 0.017 and p < 0.001 for right and left eyes respectively). We found an association between CCG and ARMD. The presence of CCG in a patient may imply increased risk for the presence of ARMD. In a patient with CCG requiring cataract or corneal surgery, the successful outcome may be compromised by the presence of ARMD.  (+info)

A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. (5/2258)

Stargardt disease (STGD) is the most common hereditary macular dystrophy and is characterized by decreased central vision, atrophy of the macula and underlying retinal-pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD is most commonly inherited as an autosomal recessive trait, but many families have been described in which features of the disease are transmitted in an autosomal dominant manner. A recessive locus has been identified on chromosome 1p (STGD1), and dominant loci have been mapped to both chromosome 13q (STGD2) and chromosome 6q (STGD3). In this study, we describe a kindred with an autosomal dominant Stargardt-like phenotype. A genomewide search demonstrated linkage to a locus on chromosome 4p, with a maximum LOD score of 5.12 at a recombination fraction of.00, for marker D4S403. Analysis of extended haplotypes localized the disease gene to an approximately 12-cM interval between loci D4S1582 and D4S2397. Therefore, this kindred establishes a new dominant Stargardt-like locus, STGD4.  (+info)

ATP binding cassette transporter retina genotypes and age related macular degeneration: an analysis on exudative non-familial Japanese patients. (6/2258)

AIM: To determine whether mutations in the Stargardt's disease gene, ATP binding cassette transporter retina (ABCR) affect the occurrence of age related macular degeneration (AMD) in Japanese non-familial patients. METHODS: 80 unrelated Japanese patients with AMD (67 males and 13 females; mean age, 67.2 years) diagnosed by indocyanine green angiography and 100 age matched control subjects were studied. Among the AMD patients, 70 (87.5%) had choroidal neovascularisation of exudative type. Genomic DNA was purified from the total blood and 10 exons (exons 11, 23, 29, 32, 34, 37, 41, 43, 44, and 49) that have been reported to contain AMD associated mutations were amplified by polymerase chain reaction (PCR). The amplicons were analysed by the single strand conformation polymorphism (SSCP) method. The nucleotide sequencing of the amplicons was determined when necessary. RESULTS: Of the 10 exons, aberrant patterns of SSCP were detected in three exons-exons 29, 41, and 43. In exon 29, an aberrant pattern was found in seven of 80 patients (8.8%) and eight of 100 controls (8%). Sequencing of the PCR products revealed a heterozygous T1428M mutation which has been previously reported as one of the AMD associated mutations. Statistical analysis showed that there was no significant difference in the occurrence of this mutation between these AMD patients and the control groups (p = 0.86). In exons 23, 41, and 43, polymorphisms and sequence variations were found. CONCLUSION: No data to support the association between the ABCR gene mutations and AMD of Japanese patients, especially that of the exudative type, were obtained in this molecular genetic analysis.  (+info)

Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study. (7/2258)

BACKGROUND/AIMS: Teletherapy has been proposed as a possible treatment for choroidal neovascular membranes (CNV), secondary to age related macular degeneration (AMD) not amenable to laser photocoagulation. The aim of this prospective study has been to investigate the effect of teletherapy on isolated occult choroidal neovascular membranes of subfoveal location. METHODS: 28 AMD patients presenting with retrofoveal isolated occult CNV demonstrated by fluorescein angiography were treated by external beam radiation. A complete ophthalmological examination, fluorescein angiography, and indocyanine green angiography (ICG) were performed within 15 days before treatment and repeated at follow up. A total dose of 16 Gy was applied in four sessions of 4 Gy using a 4 MeV photon beam. Follow up ranged from 6 to 9 months (mean follow up 6.4 months). RESULTS: Visual acuity was found to be stable in 68% of the cases. The decrease in visual acuity was of 3-6 lines in 18% and of more than 6 lines in 10% of the eyes at last examination. On fluorescein angiography the size of the lesion area was found to be stable in 67%, decreased in 13%, and increased in 20% of the cases. On ICG angiography the size of the CNV was stable in 93% and increased in 7% of the cases. All the eyes experiencing a visual acuity decrease showed either no change or an increase in size of the membrane on fluorescein angiography and/or on ICG. CONCLUSION: According to this study with strict inclusion criteria, external beam radiotherapy seems to have a beneficial effect on the evolution of isolated occult subfoveal CNV.  (+info)

North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis. (8/2258)

PURPOSE: To study the North Carolina macular dystrophy phenotype (MCDR1) in multiple families of different ethnic backgrounds, to determine the genetic relationships of these families, and to determine the minimal candidate region of the MCDR1 gene. METHODS: Thirteen families with the North Carolina MCDR1 were ascertained. These families were of various ethnic and geographic origins, such as Caucasian, Mayan Indian, African American, French, British, German, and American. Extensive genealogical investigations were performed for all families. A total of 232 members of these families underwent comprehensive ophthalmic examinations, including blood collection for genotyping. Of these, 117 were found to be affected with the disorder. Genetic linkage simulation studies were performed using the computer program SIMLINK. Two-point linkage analysis, haplotype analysis, and multipoint linkage analyses were performed using the computer programs M-LINK, VITESSE, and FASTLINK. RESULTS: The clinical features were consistent with the diagnosis of North Carolina macular dystrophy in all families studied. Multipoint linkage analysis and haplotype analysis indicate that the MCDR1 gene is in the 1.1-centimorgan (cM) interval between the genetic markers D6D249 and D6S1671, with a maximum LOD score of 40.03. There was no evidence of genetic heterogeneity. Families 765, 768, 772, 1193, and 1292 shared the same chromosomal haplotype in this region, suggesting they are the result of the same ancestral mutation. The remaining families each likely represent independent origins of the mutation in the MCDR1 gene. North Carolina macular dystrophy is present worldwide and does not emanate from a single founder from North Carolina.  (+info)

Macular degeneration, also known as age-related macular degeneration (AMD), is a medical condition that affects the central part of the retina, called the macula. The macula is responsible for sharp, detailed vision, which is necessary for activities such as reading, driving, and recognizing faces.

In AMD, there is a breakdown or deterioration of the macula, leading to gradual loss of central vision. There are two main types of AMD: dry (atrophic) and wet (exudative). Dry AMD is more common and progresses more slowly, while wet AMD is less common but can cause rapid and severe vision loss if left untreated.

The exact causes of AMD are not fully understood, but risk factors include age, smoking, family history, high blood pressure, obesity, and exposure to sunlight. While there is no cure for AMD, treatments such as vitamin supplements, laser therapy, and medication injections can help slow its progression and reduce the risk of vision loss.

Wet macular degeneration, also known as neovascular or exudative age-related macular degeneration (AMD), is a medical condition that affects the central part of the retina called the macula. It's characterized by the growth of new blood vessels (neovascularization) from the choroid layer behind the retina into the macula, which is not typical in healthy eyes. These abnormal blood vessels are fragile and prone to leakage, leading to the accumulation of fluid or blood in the macula, causing distortion or loss of central vision.

The wet form of AMD can progress rapidly and often leads to more severe visual loss compared to the dry form. It's essential to diagnose and treat wet AMD promptly to preserve as much vision as possible. Common treatments include anti-vascular endothelial growth factor (VEGF) injections, photodynamic therapy, or thermal laser treatment, depending on the specific case and individual patient factors.

Choroidal neovascularization (CNV) is a medical term that refers to the growth of new, abnormal blood vessels in the choroid layer of the eye, which is located between the retina and the sclera. This condition typically occurs as a complication of age-related macular degeneration (AMD), although it can also be caused by other eye diseases or injuries.

In CNV, the new blood vessels that grow into the choroid layer are fragile and can leak fluid or blood, which can cause distortion or damage to the retina, leading to vision loss. Symptoms of CNV may include blurred or distorted vision, a blind spot in the center of the visual field, or changes in color perception.

Treatment for CNV typically involves medications that are designed to stop the growth of new blood vessels, such as anti-VEGF drugs, which target a protein called vascular endothelial growth factor (VEGF) that is involved in the development of new blood vessels. Laser surgery or photodynamic therapy may also be used in some cases to destroy the abnormal blood vessels and prevent further vision loss.

Retinal drusen are yellow-white, deposits of extracellular material that accumulate beneath the retina, most commonly in the macula. They are a common age-related finding and can also be seen in various other conditions such as inherited retinal diseases. Drusen can vary in size and number, and their presence is often associated with an increased risk of developing age-related macular degeneration (AMD), a leading cause of vision loss in older adults. However, not all individuals with drusen will develop AMD, and the significance of drusen depends on factors such as size, number, and location. It's important to monitor drusen and have regular eye examinations to assess any changes or progression that may indicate a higher risk for developing AMD.

The retinal pigment epithelium (RPE) is a single layer of cells located between the photoreceptor cells of the retina and the choroid, which is a part of the eye containing blood vessels. The RPE plays a crucial role in maintaining the health and function of the photoreceptors by providing them with nutrients, removing waste products, and helping to regulate the light-sensitive visual pigments within the photoreceptors.

The RPE cells contain pigment granules that absorb excess light to prevent scattering within the eye and improve visual acuity. They also help to form the blood-retina barrier, which restricts the movement of certain molecules between the retina and the choroid, providing an important protective function for the retina.

Damage to the RPE can lead to a variety of eye conditions, including age-related macular degeneration (AMD), which is a leading cause of vision loss in older adults.

Retinal degeneration is a broad term that refers to the progressive loss of photoreceptor cells (rods and cones) in the retina, which are responsible for converting light into electrical signals that are sent to the brain. This process can lead to vision loss or blindness. There are many different types of retinal degeneration, including age-related macular degeneration, retinitis pigmentosa, and Stargardt's disease, among others. These conditions can have varying causes, such as genetic mutations, environmental factors, or a combination of both. Treatment options vary depending on the specific type and progression of the condition.

Geographic atrophy is a medical term used to describe a specific pattern of degeneration of the retinal pigment epithelium (RPE) and the underlying choroidal tissue in the eye. This condition is often associated with age-related macular degeneration (AMD), which is a leading cause of vision loss in older adults.

In geographic atrophy, there are well-defined areas of RPE and choroidal atrophy that appear as pale, irregularly shaped patches in the central part of the retina known as the macula. These patches can grow larger over time and may lead to progressive vision loss. The exact cause of geographic atrophy is not fully understood, but it is thought to be related to oxidative stress, inflammation, and other age-related changes in the eye.

Currently, there are no effective treatments for geographic atrophy, although research is ongoing to find new ways to slow or halt its progression. Regular eye exams and monitoring by an ophthalmologist are important for people with AMD or geographic atrophy to help detect any changes in their vision and manage their condition effectively.

Fluorescein angiography is a medical diagnostic procedure used in ophthalmology to examine the blood flow in the retina and choroid, which are the inner layers of the eye. This test involves injecting a fluorescent dye, Fluorescein, into a patient's arm vein. As the dye reaches the blood vessels in the eye, a specialized camera takes rapid sequences of photographs to capture the dye's circulation through the retina and choroid.

The images produced by fluorescein angiography can help doctors identify any damage to the blood vessels, leakage, or abnormal growth of new blood vessels. This information is crucial in diagnosing and managing various eye conditions such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, and inflammatory eye diseases.

It's important to note that while fluorescein angiography is a valuable diagnostic tool, it does carry some risks, including temporary side effects like nausea, vomiting, or allergic reactions to the dye. In rare cases, severe adverse reactions can occur, so patients should discuss these potential risks with their healthcare provider before undergoing the procedure.

The choroid is a layer of the eye that contains blood vessels that supply oxygen and nutrients to the outer layers of the retina. It lies between the sclera (the white, protective coat of the eye) and the retina (the light-sensitive tissue at the back of the eye). The choroid is essential for maintaining the health and function of the retina, particularly the photoreceptor cells that detect light and transmit visual signals to the brain. Damage to the choroid can lead to vision loss or impairment.

Visual acuity is a measure of the sharpness or clarity of vision. It is usually tested by reading an eye chart from a specific distance, such as 20 feet (6 meters). The standard eye chart used for this purpose is called the Snellen chart, which contains rows of letters that decrease in size as you read down the chart.

Visual acuity is typically expressed as a fraction, with the numerator representing the testing distance and the denominator indicating the smallest line of type that can be read clearly. For example, if a person can read the line on the eye chart that corresponds to a visual acuity of 20/20, it means they have normal vision at 20 feet. If their visual acuity is 20/40, it means they must be as close as 20 feet to see what someone with normal vision can see at 40 feet.

It's important to note that visual acuity is just one aspect of overall vision and does not necessarily reflect other important factors such as peripheral vision, depth perception, color vision, or contrast sensitivity.

Nerve degeneration, also known as neurodegeneration, is the progressive loss of structure and function of neurons, which can lead to cognitive decline, motor impairment, and various other symptoms. This process occurs due to a variety of factors, including genetics, environmental influences, and aging. It is a key feature in several neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. The degeneration can affect any part of the nervous system, leading to different symptoms depending on the location and extent of the damage.

Complement Factor H is a protein involved in the regulation of the complement system, which is a part of the immune system that helps to clear pathogens and damaged cells from the body. Specifically, Complement Factor H helps to regulate the activation and deactivation of the complement component C3b, preventing excessive or unwanted activation of the complement system and protecting host tissues from damage.

Complement Factor H is a crucial protein in maintaining the balance between the protective effects of the complement system and the potential for harm to the body's own cells and tissues. Deficiencies or mutations in Complement Factor H have been associated with several diseases, including age-related macular degeneration (AMD), atypical hemolytic uremic syndrome (aHUS), and C3 glomerulopathy.

The Bruch membrane is a thin, layered structure that separates the retina from the choroid in the eye. It is composed of five layers: the basement membrane of the retinal pigment epithelium (RPE), the inner collagenous layer, the elastic layer, the outer collagenous layer, and the basement membrane of the choriocapillaris. The Bruch membrane provides structural support to the RPE and serves as a barrier between the retina and the choroid, allowing for the selective transport of nutrients and waste products. It also plays a role in maintaining the health of the photoreceptors in the retina. Damage to the Bruch membrane is associated with age-related macular degeneration (AMD), a leading cause of vision loss in older adults.

The pigment epithelium of the eye, also known as the retinal pigment epithelium (RPE), is a layer of cells located between the photoreceptor cells of the retina and the choroid, which is the vascular layer of the eye. The RPE plays a crucial role in maintaining the health and function of the photoreceptors by providing them with nutrients, removing waste products, and helping to regulate the light that enters the eye.

The RPE cells contain pigment granules that absorb excess light, preventing it from scattering within the eye and improving visual acuity. They also help to create a barrier between the retina and the choroid, which is important for maintaining the proper functioning of the photoreceptors. Additionally, the RPE plays a role in the regeneration of visual pigments in the photoreceptor cells, allowing us to see in different light conditions.

Damage to the RPE can lead to various eye diseases and conditions, including age-related macular degeneration (AMD), which is a leading cause of vision loss in older adults.

An intravitreal injection is a medical procedure in which medication is delivered directly into the vitreous cavity of the eye, which is the clear, gel-like substance that fills the space between the lens and the retina. This type of injection is typically used to treat various eye conditions such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and uveitis. The medication administered in intravitreal injections can help to reduce inflammation, inhibit the growth of new blood vessels, or prevent the formation of abnormal blood vessels in the eye.

Intravitreal injections are usually performed in an outpatient setting, and the procedure typically takes only a few minutes. Before the injection, the eye is numbed with anesthetic drops to minimize discomfort. The medication is then injected into the vitreous cavity using a small needle. After the injection, patients may experience some mild discomfort or a scratchy sensation in the eye, but this usually resolves within a few hours.

While intravitreal injections are generally safe, there are some potential risks and complications associated with the procedure, including infection, bleeding, retinal detachment, and increased intraocular pressure. Patients who undergo intravitreal injections should be closely monitored by their eye care provider to ensure that any complications are promptly identified and treated.

The retina is the innermost, light-sensitive layer of tissue in the eye of many vertebrates and some cephalopods. It receives light that has been focused by the cornea and lens, converts it into neural signals, and sends these to the brain via the optic nerve. The retina contains several types of photoreceptor cells including rods (which handle vision in low light) and cones (which are active in bright light and are capable of color vision).

In medical terms, any pathological changes or diseases affecting the retinal structure and function can lead to visual impairment or blindness. Examples include age-related macular degeneration, diabetic retinopathy, retinal detachment, and retinitis pigmentosa among others.

The macula lutea, often simply referred to as the macula or fovea centralis, is a part of the eye that is responsible for central vision and color perception. It's located in the center of the retina, the light-sensitive tissue at the back of the eye. The macula contains a high concentration of pigments called xanthophylls, which give it a yellowish color and protect the photoreceptor cells in this area from damage by blue light.

The central part of the macula is called the fovea, which is a small depression that contains only cones, the photoreceptor cells responsible for color vision and high visual acuity. The fovea is surrounded by the parafovea and the perifovea, which contain both cones and rods, the photoreceptor cells responsible for low-light vision and peripheral vision.

Damage to the macula can result in a loss of central vision and color perception, a condition known as age-related macular degeneration (AMD), which is a leading cause of blindness in older adults. Other conditions that can affect the macula include macular edema, macular holes, and macular pucker.

Lipofuscin is a type of pigment that accumulates in the lysosomes (membrane-bound organelles found inside cells) of various tissues, particularly in nerve cells and heart muscle cells. It consists of cross-linked proteins and lipids that are resistant to degradation by enzymes. The accumulation of lipofuscin is a normal part of aging but can also be associated with certain diseases such as neurodegenerative disorders.

It's often referred to as "age pigment" because it tends to increase in amount with age, and its presence in tissues has been linked to oxidative stress and cellular damage caused by free radicals. Lipofuscin is autofluorescent, meaning that it emits light when excited by certain wavelengths of light, which can be useful for its detection and quantification in research and diagnostic settings.

Optic disk drusen are small, calcified deposits that form within the optic nerve head, also known as the optic disc. They are made up of protein and calcium salts and can vary in size and number. These deposits can be seen on ophthalmic examination using an instrument called an ophthalmoscope.

Optic disk drusen are typically asymptomatic and are often discovered during routine eye examinations. However, in some cases, they may cause visual disturbances or even vision loss if they compress the optic nerve fibers. They can also increase the risk of developing other eye conditions such as glaucoma.

Optic disk drusen are more commonly found in individuals with a family history of the condition and tend to occur in younger people, typically before the age of 40. While there is no cure for optic disk drusen, regular eye examinations can help monitor any changes in the condition and manage any associated visual symptoms or complications.

"Fundus Oculi" is a medical term that refers to the back part of the interior of the eye, including the optic disc, macula, fovea, retinal vasculature, and peripheral retina. It is the area where light is focused and then transmitted to the brain via the optic nerve, forming visual images. Examinations of the fundus oculi are crucial for detecting various eye conditions such as diabetic retinopathy, macular degeneration, glaucoma, and other retinal diseases. The examination is typically performed using an ophthalmoscope or a specialized camera called a retinal camera.

Wallerian degeneration is a process that occurs following damage to the axons of neurons (nerve cells). After an axon is severed or traumatically injured, it undergoes a series of changes including fragmentation and removal of the distal segment of the axon, which is the part that is separated from the cell body. This process is named after Augustus Waller, who first described it in 1850.

The degenerative changes in the distal axon are characterized by the breakdown of the axonal cytoskeleton, the loss of myelin sheath (the fatty insulating material that surrounds and protects the axon), and the infiltration of macrophages to clear away the debris. These events lead to the degeneration of the distal axon segment, which is necessary for successful regeneration of the injured nerve.

Wallerian degeneration is a crucial process in the nervous system's response to injury, as it enables the regrowth of axons and the reestablishment of connections between neurons. However, if the regenerative capacity of the neuron is insufficient or the environment is not conducive to growth, functional recovery may be impaired, leading to long-term neurological deficits.

Optical coherence tomography (OCT) is a non-invasive imaging technique that uses low-coherence light to capture high-resolution cross-sectional images of biological tissues, particularly the retina and other ocular structures. OCT works by measuring the echo time delay of light scattered back from different depths within the tissue, creating a detailed map of the tissue's structure. This technique is widely used in ophthalmology to diagnose and monitor various eye conditions such as macular degeneration, diabetic retinopathy, and glaucoma.

The choroid is a part of the eye located between the retina and the sclera, which contains a large number of blood vessels that supply oxygen and nutrients to the outer layers of the retina. Choroid diseases refer to various medical conditions that affect the health and function of the choroid. Here are some examples:

1. Choroidal neovascularization (CNV): This is a condition where new blood vessels grow from the choroid into the retina, leading to fluid accumulation, bleeding, and scarring. CNV can cause vision loss and is often associated with age-related macular degeneration, myopia, and inflammatory eye diseases.
2. Chorioretinitis: This is an infection or inflammation of the choroid and retina, which can be caused by various microorganisms such as bacteria, viruses, fungi, or parasites. Symptoms may include blurred vision, floaters, light sensitivity, and eye pain.
3. Choroidal hemorrhage: This is a rare but serious condition where there is bleeding into the choroid, often caused by trauma, high blood pressure, or blood clotting disorders. It can lead to sudden vision loss and requires urgent medical attention.
4. Choroideremia: This is a genetic disorder that affects the choroid, retina, and optic nerve, leading to progressive vision loss. It is caused by mutations in the CHM gene and primarily affects males.
5. Central serous retinopathy (CSR): This is a condition where fluid accumulates under the retina, often in the macula, causing distortion or blurring of vision. While the exact cause is unknown, CSR is thought to be related to stress, steroid use, and other factors that affect the choroid's ability to regulate fluid.
6. Polypoidal choroidal vasculopathy (PCV): This is a condition where abnormal blood vessels form in the choroid, leading to serous or hemorrhagic detachment of the retina. PCV is often associated with age-related macular degeneration and can cause vision loss if left untreated.

These are just a few examples of choroidal disorders that can affect vision. If you experience any sudden changes in your vision, it's important to seek medical attention promptly.

Lutein is a type of carotenoid, specifically a xanthophyll, that is naturally present in many fruits and vegetables. It is considered a dietary antioxidant with potential health benefits for the eyes. Lutein is not a vitamin, but it is often grouped with vitamins and minerals because of its importance to human health.

In the eye, lutein is selectively accumulated in the macula, a small area in the center of the retina responsible for sharp, detailed vision. It helps filter harmful blue light and protects the eye from oxidative damage, which may help maintain eye health and reduce the risk of age-related macular degeneration (AMD), a leading cause of blindness in older adults.

It is important to note that lutein is not produced by the human body and must be obtained through dietary sources or supplements. Foods rich in lutein include dark leafy greens, such as spinach and kale, as well as other fruits and vegetables, such as corn, orange pepper, and egg yolk.

The fovea centralis, also known as the macula lutea, is a small pit or depression located in the center of the retina, an light-sensitive tissue at the back of the eye. It is responsible for sharp, detailed vision (central vision) and color perception. The fovea contains only cones, the photoreceptor cells that are responsible for color vision and high visual acuity. It has a higher concentration of cones than any other area in the retina, allowing it to provide the greatest detail and color discrimination. The center of the fovea is called the foveola, which contains the highest density of cones and is avascular, meaning it lacks blood vessels to avoid interfering with the light passing through to the photoreceptor cells.

Photoreceptor cells in vertebrates are specialized types of neurons located in the retina of the eye that are responsible for converting light stimuli into electrical signals. These cells are primarily responsible for the initial process of vision and have two main types: rods and cones.

Rods are more numerous and are responsible for low-light vision or scotopic vision, enabling us to see in dimly lit conditions. They do not contribute to color vision but provide information about the shape and movement of objects.

Cones, on the other hand, are less numerous and are responsible for color vision and high-acuity vision or photopic vision. There are three types of cones, each sensitive to different wavelengths of light: short (S), medium (M), and long (L) wavelengths, which correspond to blue, green, and red, respectively. The combination of signals from these three types of cones allows us to perceive a wide range of colors.

Both rods and cones contain photopigments that consist of a protein called opsin and a light-sensitive chromophore called retinal. When light hits the photopigment, it triggers a series of chemical reactions that ultimately lead to the generation of an electrical signal that is transmitted to the brain via the optic nerve. This process enables us to see and perceive our visual world.

Angiogenesis inhibitors are a class of drugs that block the growth of new blood vessels (angiogenesis). They work by targeting specific molecules involved in the process of angiogenesis, such as vascular endothelial growth factor (VEGF) and its receptors. By blocking these molecules, angiogenesis inhibitors can prevent the development of new blood vessels that feed tumors, thereby slowing or stopping their growth.

Angiogenesis inhibitors are used in the treatment of various types of cancer, including colon, lung, breast, kidney, and ovarian cancer. They may be given alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy. Some examples of angiogenesis inhibitors include bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent), and pazopanib (Votrient).

It's important to note that while angiogenesis inhibitors can be effective in treating cancer, they can also have serious side effects, such as high blood pressure, bleeding, and damage to the heart or kidneys. Therefore, it's essential that patients receive careful monitoring and management of these potential side effects while undergoing treatment with angiogenesis inhibitors.

Retinal neovascularization is a medical condition characterized by the growth of new, abnormal blood vessels on the surface of the retina, which is the light-sensitive tissue located at the back of the eye. This condition typically occurs in response to an insufficient supply of oxygen and nutrients to the retina, often due to damage or disease, such as diabetic retinopathy or retinal vein occlusion.

The new blood vessels that form during neovascularization are fragile and prone to leakage, which can cause fluid and protein to accumulate in the retina, leading to distorted vision, hemorrhages, and potentially blindness if left untreated. Retinal neovascularization is a serious eye condition that requires prompt medical attention and management to prevent further vision loss.

Electroretinography (ERG) is a medical test used to evaluate the functioning of the retina, which is the light-sensitive tissue located at the back of the eye. The test measures the electrical responses of the retina to light stimulation.

During the procedure, a special contact lens or electrode is placed on the surface of the eye to record the electrical activity generated by the retina's light-sensitive cells (rods and cones) and other cells in the retina. The test typically involves presenting different levels of flashes of light to the eye while the electrical responses are recorded.

The resulting ERG waveform provides information about the overall health and function of the retina, including the condition of the photoreceptors, the integrity of the inner retinal layers, and the health of the retinal ganglion cells. This test is often used to diagnose and monitor various retinal disorders, such as retinitis pigmentosa, macular degeneration, and diabetic retinopathy.

Exudates and transudates are two types of bodily fluids that can accumulate in various body cavities or tissues as a result of injury, inflammation, or other medical conditions. Here are the medical definitions:

1. Exudates: These are fluids that accumulate due to an active inflammatory process. Exudates contain high levels of protein, white blood cells (such as neutrophils and macrophages), and sometimes other cells like red blood cells or cellular debris. They can be yellow, green, or brown in color and may have a foul odor due to the presence of dead cells and bacteria. Exudates are often seen in conditions such as abscesses, pneumonia, pleurisy, or wound infections.

Examples of exudative fluids include pus, purulent discharge, or inflammatory effusions.

2. Transudates: These are fluids that accumulate due to increased hydrostatic pressure or decreased oncotic pressure within the blood vessels. Transudates contain low levels of protein and cells compared to exudates. They are typically clear and pale yellow in color, with no odor. Transudates can be found in conditions such as congestive heart failure, liver cirrhosis, or nephrotic syndrome.

Examples of transudative fluids include ascites, pleural effusions, or pericardial effusions.

It is essential to differentiate between exudates and transudates because their underlying causes and treatment approaches may differ significantly. Medical professionals often use various tests, such as fluid analysis, to determine whether a fluid sample is an exudate or transudate.

Photochemotherapy is a medical treatment that combines the use of drugs and light to treat various skin conditions. The most common type of photochemotherapy is PUVA (Psoralen + UVA), where the patient takes a photosensitizing medication called psoralen, followed by exposure to ultraviolet A (UVA) light.

The psoralen makes the skin more sensitive to the UVA light, which helps to reduce inflammation and suppress the overactive immune response that contributes to many skin conditions. This therapy is often used to treat severe cases of psoriasis, eczema, and mycosis fungoides (a type of cutaneous T-cell lymphoma). It's important to note that photochemotherapy can increase the risk of skin cancer and cataracts, so it should only be administered under the close supervision of a healthcare professional.

Eye proteins, also known as ocular proteins, are specific proteins that are found within the eye and play crucial roles in maintaining proper eye function and health. These proteins can be found in various parts of the eye, including the cornea, iris, lens, retina, and other structures. They perform a wide range of functions, such as:

1. Structural support: Proteins like collagen and elastin provide strength and flexibility to the eye's tissues, enabling them to maintain their shape and withstand mechanical stress.
2. Light absorption and transmission: Proteins like opsins and crystallins are involved in capturing and transmitting light signals within the eye, which is essential for vision.
3. Protection against damage: Some eye proteins, such as antioxidant enzymes and heat shock proteins, help protect the eye from oxidative stress, UV radiation, and other environmental factors that can cause damage.
4. Regulation of eye growth and development: Various growth factors and signaling molecules, which are protein-based, contribute to the proper growth, differentiation, and maintenance of eye tissues during embryonic development and throughout adulthood.
5. Immune defense: Proteins involved in the immune response, such as complement components and immunoglobulins, help protect the eye from infection and inflammation.
6. Maintenance of transparency: Crystallin proteins in the lens maintain its transparency, allowing light to pass through unobstructed for clear vision.
7. Neuroprotection: Certain eye proteins, like brain-derived neurotrophic factor (BDNF), support the survival and function of neurons within the retina, helping to preserve vision.

Dysfunction or damage to these eye proteins can contribute to various eye disorders and diseases, such as cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and others.

Intervertebral disc degeneration is a physiological and biochemical process that occurs in the spinal discs, which are located between each vertebra in the spine. These discs act as shock absorbers and allow for movement and flexibility of the spine.

The degenerative process involves changes in the structure and composition of the disc, including loss of water content, decreased production of proteoglycans (which help to maintain the disc's elasticity), and disorganization of the collagen fibers that make up the disc's outer layer (annulus fibrosus). These changes can lead to a decrease in the disc's height and mobility, as well as the development of tears or cracks in the annulus fibrosus.

In advanced stages of degeneration, the disc may herniate or bulge outward, causing pressure on nearby nerves and potentially leading to pain, numbness, tingling, or weakness in the affected area. It's worth noting that while intervertebral disc degeneration is a normal part of aging, certain factors such as injury, smoking, obesity, and repetitive stress can accelerate the process.

Ophthalmoscopy is a medical examination technique used by healthcare professionals to observe the interior structures of the eye, including the retina, optic disc, and vitreous humor. This procedure typically involves using an ophthalmoscope, a handheld device that consists of a light and magnifying lenses. The healthcare provider looks through the ophthalmoscope and directly observes the internal structures of the eye by illuminating them.

There are several types of ophthalmoscopy, including direct ophthalmoscopy, indirect ophthalmoscopy, and slit-lamp biomicroscopy. Each type has its own advantages and disadvantages, and they may be used in different situations depending on the specific clinical situation and the information needed.

Ophthalmoscopy is an important diagnostic tool for detecting and monitoring a wide range of eye conditions, including diabetic retinopathy, glaucoma, age-related macular degeneration, and other retinal disorders. It can also provide valuable information about the overall health of the individual, as changes in the appearance of the retina or optic nerve may indicate the presence of systemic diseases such as hypertension or diabetes.

Xanthophylls are a type of pigment known as carotenoids, which are naturally occurring in various plants and animals. They are characterized by their yellow to orange color and play an important role in photosynthesis. Unlike other carotenoids, xanthophylls contain oxygen in their chemical structure.

In the context of human health, xanthophylls are often studied for their potential antioxidant properties and their possible role in reducing the risk of age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The two main dietary sources of xanthophylls are lutein and zeaxanthin, which are found in green leafy vegetables, such as spinach and kale, as well as in other fruits and vegetables.

It's important to note that while a healthy diet rich in fruits and vegetables has many benefits for overall health, including eye health, more research is needed to fully understand the specific role of xanthophylls in preventing or treating diseases.

Subretinal fluid (SRF) refers to the abnormal accumulation of fluid between the neurosensory retina and the pigment epithelium of the eye. This can occur due to various conditions such as age-related macular degeneration, central serous chorioretinopathy, or retinal detachment. The presence of subretinal fluid can distort vision and may require medical intervention depending on the underlying cause and severity of the condition.

I'm sorry for any confusion, but "photography" is not a term typically used in medical definitions. Photography refers to the art, application, or process of creating images by recording light or other electromagnetic radiation, either electronically by means of an image sensor, or chemically by means of a light-sensitive material such as photographic film.

If you're looking for a medical term related to imaging, there are several terms that might be relevant, such as:

1. Radiography: This is a technique using X-rays to visualize the internal structures of the body.
2. Ultrasonography: Also known as ultrasound, this is a diagnostic imaging technique using high-frequency sound waves to create images of the inside of the body.
3. Computed Tomography (CT): A type of imaging that uses X-rays to create detailed cross-sectional images of the body.
4. Magnetic Resonance Imaging (MRI): A type of imaging that uses magnetic fields and radio waves to create detailed images of the organs and tissues within the body.
5. Nuclear Medicine: This is a branch of medical imaging that uses small amounts of radioactive material to diagnose and treat diseases.

If you have any questions related to medical definitions or topics, feel free to ask!

A scotoma is a blind spot or area of reduced vision within the visual field. It's often surrounded by an area of less distinct vision and can be caused by various conditions such as eye diseases, neurological disorders, or brain injuries. A scotoma may be temporary or permanent, depending on its underlying cause.

There are different types of scotomas, including:

1. Central scotoma - a blind spot in the center of the visual field, often associated with conditions like age-related macular degeneration and diabetic retinopathy.
2. Paracentral scotoma - a blind spot located slightly away from the center of the visual field, which can be caused by optic neuritis or other optic nerve disorders.
3. Peripheral scotoma - a blind spot in the peripheral vision, often associated with retinal diseases like retinitis pigmentosa.
4. Absolute scotoma - a complete loss of vision in a specific area of the visual field.
5. Relative scotoma - a partial loss of vision in which some details can still be perceived, but not as clearly or vividly as in normal vision.

It is essential to consult an eye care professional if you experience any changes in your vision or notice a scotoma, as early detection and treatment can help prevent further vision loss.

Retinal diseases refer to a group of conditions that affect the retina, which is the light-sensitive tissue located at the back of the eye. The retina is responsible for converting light into electrical signals that are sent to the brain and interpreted as visual images. Retinal diseases can cause vision loss or even blindness, depending on their severity and location in the retina.

Some common retinal diseases include:

1. Age-related macular degeneration (AMD): A progressive disease that affects the central part of the retina called the macula, causing blurred or distorted vision.
2. Diabetic retinopathy: A complication of diabetes that can damage the blood vessels in the retina, leading to vision loss.
3. Retinal detachment: A serious condition where the retina becomes separated from its underlying tissue, requiring immediate medical attention.
4. Macular edema: Swelling or thickening of the macula due to fluid accumulation, which can cause blurred vision.
5. Retinitis pigmentosa: A group of inherited eye disorders that affect the retina's ability to respond to light, causing progressive vision loss.
6. Macular hole: A small break in the macula that can cause distorted or blurry vision.
7. Retinal vein occlusion: Blockage of the retinal veins that can lead to bleeding, swelling, and potential vision loss.

Treatment for retinal diseases varies depending on the specific condition and its severity. Some treatments include medication, laser therapy, surgery, or a combination of these options. Regular eye exams are essential for early detection and treatment of retinal diseases.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

Monoclonal antibodies are laboratory-produced proteins that mimic the immune system's ability to fight off harmful antigens such as viruses and cancer cells. They are created by fusing a single B cell (the type of white blood cell responsible for producing antibodies) with a tumor cell, resulting in a hybrid cell called a hybridoma. This hybridoma can then be cloned to produce a large number of identical cells, all producing the same antibody, hence "monoclonal."

Humanized monoclonal antibodies are a type of monoclonal antibody that have been genetically engineered to include human components. This is done to reduce the risk of an adverse immune response in patients receiving the treatment. In this process, the variable region of the mouse monoclonal antibody, which contains the antigen-binding site, is grafted onto a human constant region. The resulting humanized monoclonal antibody retains the ability to bind to the target antigen while minimizing the immunogenicity associated with murine (mouse) antibodies.

In summary, "antibodies, monoclonal, humanized" refers to a type of laboratory-produced protein that mimics the immune system's ability to fight off harmful antigens, but with reduced immunogenicity due to the inclusion of human components in their structure.

Eye diseases are a range of conditions that affect the eye or visual system, causing damage to vision and, in some cases, leading to blindness. These diseases can be categorized into various types, including:

1. Refractive errors: These include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, which affect the way light is focused on the retina and can usually be corrected with glasses or contact lenses.
2. Cataracts: A clouding of the lens inside the eye that leads to blurry vision, glare, and decreased contrast sensitivity. Cataract surgery is the most common treatment for this condition.
3. Glaucoma: A group of diseases characterized by increased pressure in the eye, leading to damage to the optic nerve and potential blindness if left untreated. Treatment includes medications, laser therapy, or surgery.
4. Age-related macular degeneration (AMD): A progressive condition that affects the central part of the retina called the macula, causing blurry vision and, in advanced stages, loss of central vision. Treatment may include anti-VEGF injections, laser therapy, or nutritional supplements.
5. Diabetic retinopathy: A complication of diabetes that affects the blood vessels in the retina, leading to bleeding, leakage, and potential blindness if left untreated. Treatment includes laser therapy, anti-VEGF injections, or surgery.
6. Retinal detachment: A separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly with surgery.
7. Amblyopia (lazy eye): A condition where one eye does not develop normal vision, often due to a misalignment or refractive error in childhood. Treatment includes correcting the underlying problem and encouraging the use of the weaker eye through patching or other methods.
8. Strabismus (crossed eyes): A misalignment of the eyes that can lead to amblyopia if not treated promptly with surgery, glasses, or other methods.
9. Corneal diseases: Conditions that affect the transparent outer layer of the eye, such as keratoconus, Fuchs' dystrophy, and infectious keratitis, which can lead to vision loss if not treated promptly.
10. Uveitis: Inflammation of the middle layer of the eye, which can cause vision loss if not treated promptly with anti-inflammatory medications or surgery.

Retinal detachment is a serious eye condition that occurs when the retina, a thin layer of tissue at the back of the eye responsible for processing light and sending visual signals to the brain, pulls away from its normal position. This can lead to significant vision loss or even blindness if not promptly treated. Retinal detachment can be caused by various factors such as aging, trauma, eye disease, or an inflammatory condition. Symptoms of retinal detachment may include sudden flashes of light, floaters, a shadow in the peripheral vision, or a curtain-like covering over part of the visual field. Immediate medical attention is necessary to prevent further damage and preserve vision.

A retinal hemorrhage is a type of bleeding that occurs in the blood vessels of the retina, which is the light-sensitive tissue located at the back of the eye. This condition can result from various underlying causes, including diabetes, high blood pressure, age-related macular degeneration, or trauma to the eye. Retinal hemorrhages can be categorized into different types based on their location and appearance, such as dot and blot hemorrhages, flame-shaped hemorrhages, or subhyaloid hemorrhages. Depending on the severity and cause of the hemorrhage, treatment options may vary from monitoring to laser therapy, medication, or even surgery. It is essential to consult an ophthalmologist for a proper evaluation and management plan if you suspect a retinal hemorrhage.

Vision disorders refer to a wide range of conditions that affect the visual system and result in various symptoms, such as blurry vision, double vision, distorted vision, impaired depth perception, and difficulty with visual tracking or focusing. These disorders can be categorized into several types, including:

1. Refractive errors: These occur when the shape of the eye prevents light from focusing directly on the retina, resulting in blurry vision. Examples include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision).
2. Strabismus: Also known as crossed eyes or walleye, strabismus is a misalignment of the eyes where they point in different directions, which can lead to double vision or loss of depth perception.
3. Amblyopia: Often called lazy eye, amblyopia is a condition where one eye has reduced vision due to lack of proper visual development during childhood. It may be caused by strabismus, refractive errors, or other factors that interfere with normal visual development.
4. Accommodative disorders: These involve problems with the focusing ability of the eyes, such as convergence insufficiency (difficulty focusing on close objects) and accommodative dysfunction (inability to maintain clear vision at different distances).
5. Binocular vision disorders: These affect how the eyes work together as a team, leading to issues like poor depth perception, eye strain, and headaches. Examples include convergence insufficiency, divergence excess, and suppression.
6. Ocular motility disorders: These involve problems with eye movement, such as nystagmus (involuntary eye movements), strabismus, or restricted extraocular muscle function.
7. Visual processing disorders: These affect the brain's ability to interpret and make sense of visual information, even when the eyes themselves are healthy. Symptoms may include difficulty with reading, recognizing shapes and objects, and understanding spatial relationships.
8. Low vision: This term refers to significant visual impairment that cannot be fully corrected with glasses, contact lenses, medication, or surgery. It includes conditions like macular degeneration, diabetic retinopathy, glaucoma, and cataracts.
9. Blindness: Complete loss of sight in both eyes, which can be caused by various factors such as injury, disease, or genetic conditions.

Low vision is a term used to describe significant visual impairment that cannot be corrected with standard glasses, contact lenses, medication or surgery. It is typically defined as visual acuity of less than 20/70 in the better-seeing eye after best correction, or a visual field of less than 20 degrees in the better-seeing eye.

People with low vision may have difficulty performing everyday tasks such as reading, recognizing faces, watching television, driving, or simply navigating their environment. They may also experience symptoms such as sensitivity to light, glare, or contrast, and may benefit from the use of visual aids, assistive devices, and rehabilitation services to help them maximize their remaining vision and maintain their independence.

Low vision can result from a variety of causes, including eye diseases such as macular degeneration, diabetic retinopathy, glaucoma, or cataracts, as well as congenital or inherited conditions, brain injuries, or aging. It is important for individuals with low vision to receive regular eye examinations and consult with a low vision specialist to determine the best course of treatment and management.

Complement Factor B is a protein that plays a crucial role in the complement system, which is a part of the immune system that helps to eliminate pathogens and damaged cells from the body. Specifically, Factor B is a component of the alternative pathway of the complement system, which provides a rapid and amplified response to microbial surfaces.

Factor B is cleaved by another protease called Factor D into two fragments, Ba and Bb. The formation of the C3 convertase (C3bBb) is essential for the activation of the alternative pathway. This complex can cleave and activate more C3 molecules, leading to a cascade of reactions that result in the formation of the membrane attack complex (MAC), which forms pores in the membranes of target cells, causing their lysis and elimination.

Deficiencies or mutations in Complement Factor B can lead to various complement-mediated diseases, such as atypical hemolytic uremic syndrome (aHUS) and age-related macular degeneration (AMD).

Indocyanine green (ICG) is a sterile, water-soluble, tricarbocyanine dye that is used as a diagnostic agent in medical imaging. It is primarily used in ophthalmology for fluorescein angiography to examine blood flow in the retina and choroid, and in cardiac surgery to assess cardiac output and perfusion. When injected into the body, ICG binds to plasma proteins and fluoresces when exposed to near-infrared light, allowing for visualization of various tissues and structures. It is excreted primarily by the liver and has a half-life of approximately 3-4 minutes in the bloodstream.

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide (A, T, C, or G) in the DNA sequence is altered. This alteration must occur in at least 1% of the population to be considered a SNP. These variations can help explain why some people are more susceptible to certain diseases than others and can also influence how an individual responds to certain medications. SNPs can serve as biological markers, helping scientists locate genes that are associated with disease. They can also provide information about an individual's ancestry and ethnic background.

Laser coagulation, also known as laser photocoagulation, is a medical procedure that uses a laser to seal or destroy abnormal blood vessels or tissue. The laser produces a concentrated beam of light that can be precisely focused on the target area. When the laser energy is absorbed by the tissue, it causes the temperature to rise, which leads to coagulation (the formation of a clot) or destruction of the tissue.

In ophthalmology, laser coagulation is commonly used to treat conditions such as diabetic retinopathy, age-related macular degeneration, and retinal tears or holes. The procedure can help to seal leaking blood vessels, reduce fluid leakage, and prevent further vision loss. It is usually performed as an outpatient procedure and may be repeated if necessary.

In other medical specialties, laser coagulation may be used to control bleeding, destroy tumors, or remove unwanted tissue. The specific technique and parameters of the laser treatment will depend on the individual patient's needs and the condition being treated.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Blindness is a condition of complete or near-complete vision loss. It can be caused by various factors such as eye diseases, injuries, or birth defects. Total blindness means that a person cannot see anything at all, while near-complete blindness refers to having only light perception or the ability to perceive the direction of light, but not able to discern shapes or forms. Legal blindness is a term used to define a certain level of visual impairment that qualifies an individual for government assistance and benefits; it usually means best corrected visual acuity of 20/200 or worse in the better eye, or a visual field no greater than 20 degrees in diameter.

Vision tests are a series of procedures used to assess various aspects of the visual system, including visual acuity, accommodation, convergence, divergence, stereopsis, color vision, and peripheral vision. These tests help healthcare professionals diagnose and manage vision disorders, such as nearsightedness, farsightedness, astigmatism, amblyopia, strabismus, and eye diseases like glaucoma, cataracts, and macular degeneration. Common vision tests include:

1. Visual acuity test (Snellen chart or letter chart): Measures the sharpness of a person's vision at different distances.
2. Refraction test: Determines the correct lens prescription for glasses or contact lenses by assessing how light is bent as it passes through the eye.
3. Color vision test: Evaluates the ability to distinguish between different colors and color combinations, often using pseudoisochromatic plates or Ishihara tests.
4. Stereopsis test: Assesses depth perception and binocular vision by presenting separate images to each eye that, when combined, create a three-dimensional effect.
5. Cover test: Examines eye alignment and the presence of strabismus (crossed eyes or turned eyes) by covering and uncovering each eye while observing eye movements.
6. Ocular motility test: Assesses the ability to move the eyes in various directions and coordinate both eyes during tracking and convergence/divergence movements.
7. Accommodation test: Evaluates the ability to focus on objects at different distances by using lenses, prisms, or dynamic retinoscopy.
8. Pupillary response test: Examines the size and reaction of the pupils to light and near objects.
9. Visual field test: Measures the peripheral (side) vision using automated perimetry or manual confrontation techniques.
10. Slit-lamp examination: Inspects the structures of the front part of the eye, such as the cornea, iris, lens, and anterior chamber, using a specialized microscope.

These tests are typically performed by optometrists, ophthalmologists, or other vision care professionals during routine eye examinations or when visual symptoms are present.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Vascular Endothelial Growth Factor A (VEGFA) is a specific isoform of the vascular endothelial growth factor (VEGF) family. It is a well-characterized signaling protein that plays a crucial role in angiogenesis, the process of new blood vessel formation from pre-existing vessels. VEGFA stimulates the proliferation and migration of endothelial cells, which line the interior surface of blood vessels, thereby contributing to the growth and development of new vasculature. This protein is essential for physiological processes such as embryonic development and wound healing, but it has also been implicated in various pathological conditions, including cancer, age-related macular degeneration, and diabetic retinopathy. The regulation of VEGFA expression and activity is critical to maintaining proper vascular function and homeostasis.

Complement C2 is a protein that plays a crucial role in the complement system, which is a part of the immune system that helps to eliminate pathogens and damaged cells from the body. Specifically, C2 is a component of the classical complement pathway, which is activated by the binding of antibodies to antigens on the surface of foreign particles or cells.

When the classical pathway is activated, C2 is cleaved into two fragments: C2a and C2b. C2a then binds to C4b to form the C3 convertase (C4b2a), which cleaves C3 into C3a and C3b. C3b can then go on to form the membrane attack complex, which creates a pore in the membrane of the target cell, leading to its lysis.

In summary, Complement C2 is a protein that helps to activate the complement system and destroy foreign particles or cells through the formation of the C3 convertase and the membrane attack complex.

Retinitis pigmentosa (RP) is a group of rare, genetic disorders that involve a breakdown and loss of cells in the retina - a light-sensitive tissue located at the back of the eye. The retina converts light into electrical signals which are then sent to the brain and interpreted as visual images.

In RP, the cells that detect light (rods and cones) degenerate more slowly than other cells in the retina, leading to a progressive loss of vision. Symptoms typically begin in childhood with night blindness (difficulty seeing in low light), followed by a gradual narrowing of the visual field (tunnel vision). Over time, this can lead to significant vision loss and even blindness.

The condition is usually inherited and there are several different genes that have been associated with RP. The diagnosis is typically made based on a combination of genetic testing, family history, and clinical examination. Currently, there is no cure for RP, but researchers are actively working to develop new treatments that may help slow or stop the progression of the disease.

Hereditary eye diseases refer to conditions that affect the eyes and are passed down from parents to their offspring through genetics. These diseases are caused by mutations or changes in an individual's DNA that are inherited from their parents. The mutations can occur in any of the genes associated with eye development, function, or health.

There are many different types of hereditary eye diseases, some of which include:

1. Retinitis Pigmentosa - a group of rare, genetic disorders that involve a breakdown and loss of cells in the retina.
2. Macular Degeneration - a progressive disease that damages the central portion of the retina, impairing vision.
3. Glaucoma - a group of eye conditions that damage the optic nerve, often caused by an increase in pressure inside the eye.
4. Cataracts - clouding of the lens inside the eye, which can lead to blurry vision and blindness.
5. Keratoconus - a progressive eye disease that causes the cornea to thin and bulge outward into a cone shape.
6. Color Blindness - a condition where an individual has difficulty distinguishing between certain colors.
7. Optic Neuropathy - damage to the optic nerve, which can result in vision loss.

The symptoms and severity of hereditary eye diseases can vary widely depending on the specific condition and the individual's genetic makeup. Some conditions may be present at birth or develop in early childhood, while others may not appear until later in life. Treatment options for these conditions may include medication, surgery, or lifestyle changes, and are often most effective when started early.

Photosensitizing agents are substances that, when exposed to light, particularly ultraviolet or visible light, can cause chemical reactions leading to the production of reactive oxygen species. These reactive oxygen species can interact with biological tissues, leading to damage and a variety of phototoxic or photoallergic adverse effects.

Photosensitizing agents are used in various medical fields, including dermatology and oncology. In dermatology, they are often used in the treatment of conditions such as psoriasis and eczema, where a photosensitizer is applied to the skin and then activated with light to reduce inflammation and slow the growth of skin cells.

In oncology, photosensitizing agents are used in photodynamic therapy (PDT), a type of cancer treatment that involves administering a photosensitizer, allowing it to accumulate in cancer cells, and then exposing the area to light. The light activates the photosensitizer, which produces reactive oxygen species that damage the cancer cells, leading to their death.

Examples of photosensitizing agents include porphyrins, chlorophyll derivatives, and certain antibiotics such as tetracyclines and fluoroquinolones. It is important for healthcare providers to be aware of the potential for photosensitivity when prescribing these medications and to inform patients of the risks associated with exposure to light.

Frontotemporal lobar degeneration (FTLD) is a group of disorders characterized by the progressive degeneration of the frontal and temporal lobes of the brain. These areas of the brain are involved in decision-making, behavior, emotion, and language. FTLD can be divided into several subtypes based on the specific clinical features and the underlying protein abnormalities.

The three main subtypes of FTLD are:

1. Behavioral variant frontotemporal dementia (bvFTD): This subtype is characterized by changes in personality, behavior, and judgment. People with bvFTD may lose their social inhibitions, become impulsive, or develop compulsive behaviors. They may also have difficulty with emotional processing and empathy.
2. Primary progressive aphasia (PPA): This subtype is characterized by the gradual deterioration of language skills. People with PPA may have difficulty speaking, understanding spoken or written language, or both. There are three subtypes of PPA: nonfluent/agrammatic variant, semantic variant, and logopenic variant.
3. Motor neuron disease (MND) with FTLD: This subtype is characterized by the degeneration of motor neurons, which are the nerve cells responsible for controlling voluntary muscle movements. People with MND with FTLD may develop symptoms of amyotrophic lateral sclerosis (ALS), such as muscle weakness, stiffness, and twitching, as well as cognitive and behavioral changes associated with FTLD.

The underlying protein abnormalities in FTLD include:

1. Tau protein: In some forms of FTLD, the tau protein accumulates and forms clumps called tangles inside nerve cells. This is also seen in Alzheimer's disease.
2. TDP-43 protein: In other forms of FTLD, the TDP-43 protein accumulates and forms clumps inside nerve cells.
3. Fused in sarcoma (FUS) protein: In a small number of cases, the FUS protein accumulates and forms clumps inside nerve cells.

FTLD is typically a progressive disorder, meaning that symptoms worsen over time. There is currently no cure for FTLD, but there are treatments available to help manage symptoms and improve quality of life.

A cataract is a clouding of the natural lens in the eye that affects vision. This clouding can cause vision to become blurry, faded, or dim, making it difficult to see clearly. Cataracts are a common age-related condition, but they can also be caused by injury, disease, or medication use. In most cases, cataracts develop gradually over time and can be treated with surgery to remove the cloudy lens and replace it with an artificial one.

Retinoids are a class of chemical compounds that are derivatives of vitamin A. They are widely used in dermatology for the treatment of various skin conditions, including acne, psoriasis, and photoaging. Retinoids can help to reduce inflammation, improve skin texture and tone, and stimulate collagen production.

Retinoids work by binding to specific receptors in the skin cells, which triggers a series of biochemical reactions that regulate gene expression and promote cell differentiation and turnover. This can help to unclog pores, reduce the appearance of fine lines and wrinkles, and improve the overall health and appearance of the skin.

There are several different types of retinoids used in skincare products, including retinoic acid, retinaldehyde, and retinol. Retinoic acid is the most potent form of retinoid and is available by prescription only. Retinaldehyde and retinol are weaker forms of retinoid that can be found in over-the-counter skincare products.

While retinoids can be highly effective for treating various skin conditions, they can also cause side effects such as dryness, irritation, and sensitivity to the sun. It is important to use retinoids as directed by a healthcare professional and to follow proper sun protection measures when using these products.

Retinal pigments refer to the light-sensitive chemicals found in the retina, specifically within the photoreceptor cells called rods and cones. The main types of retinal pigments are rhodopsin (also known as visual purple) in rods and iodopsins in cones. These pigments play a crucial role in the process of vision by absorbing light and initiating a series of chemical reactions that ultimately trigger nerve impulses, which are then transmitted to the brain and interpreted as visual images. Rhodopsin is more sensitive to lower light levels and is responsible for night vision, while iodopsins are sensitive to specific wavelengths of light and contribute to color vision.

Porphyrins are complex organic compounds that contain four pyrrole rings joined together by methine bridges (=CH-). They play a crucial role in the biochemistry of many organisms, as they form the core structure of various heme proteins and other metalloproteins. Some examples of these proteins include hemoglobin, myoglobin, cytochromes, and catalases, which are involved in essential processes such as oxygen transport, electron transfer, and oxidative metabolism.

In the human body, porphyrins are synthesized through a series of enzymatic reactions known as the heme biosynthesis pathway. Disruptions in this pathway can lead to an accumulation of porphyrins or their precursors, resulting in various medical conditions called porphyrias. These disorders can manifest as neurological symptoms, skin lesions, and gastrointestinal issues, depending on the specific type of porphyria and the site of enzyme deficiency.

It is important to note that while porphyrins are essential for life, their accumulation in excessive amounts or at inappropriate locations can result in pathological conditions. Therefore, understanding the regulation and function of porphyrin metabolism is crucial for diagnosing and managing porphyrias and other related disorders.

Atrophy is a medical term that refers to the decrease in size and wasting of an organ or tissue due to the disappearance of cells, shrinkage of cells, or decreased number of cells. This process can be caused by various factors such as disuse, aging, degeneration, injury, or disease.

For example, if a muscle is immobilized for an extended period, it may undergo atrophy due to lack of use. Similarly, certain medical conditions like diabetes, cancer, and heart failure can lead to the wasting away of various tissues and organs in the body.

Atrophy can also occur as a result of natural aging processes, leading to decreased muscle mass and strength in older adults. In general, atrophy is characterized by a decrease in the volume or weight of an organ or tissue, which can have significant impacts on its function and overall health.

"Light coagulation," also known as "laser coagulation," is a medical term that refers to the use of laser technology to cauterize (seal or close) tissue. This procedure uses heat generated by a laser to cut, coagulate, or destroy tissue. In light coagulation, the laser beam is focused on the blood vessels in question, causing the blood within them to clot and the vessels to seal. This can be used for various medical purposes, such as stopping bleeding during surgery, destroying abnormal tissues (like tumors), or treating eye conditions like diabetic retinopathy and age-related macular degeneration.

It's important to note that this is a general definition, and the specific use of light coagulation may vary depending on the medical specialty and the individual patient's needs. As always, it's best to consult with a healthcare professional for more detailed information about any medical procedure or treatment.

The retinal photoreceptor cells, namely rods and cones, are specialized neurons in the retina responsible for converting light into electrical signals that can be processed by the brain. The outer segment of a retinal photoreceptor cell is the portion of the cell where phototransduction primarily occurs. It contains stacks of disc-like structures filled with the visual pigment rhodopsin, which absorbs light and initiates the conversion process.

The outer segment is continuously renewed through a process called shedding and phagocytosis, in which the oldest discs at the base of the outer segment are shed, engulfed by the adjacent retinal pigment epithelium (RPE) cells, and degraded. This turnover helps maintain the sensitivity and functionality of the photoreceptor cells.

In summary, the retinal photoreceptor cell outer segment is a highly specialized compartment where light absorption and initial signal transduction occur in rods and cones, supported by continuous renewal through shedding and phagocytosis.

Genetic predisposition to disease refers to an increased susceptibility or vulnerability to develop a particular illness or condition due to inheriting specific genetic variations or mutations from one's parents. These genetic factors can make it more likely for an individual to develop a certain disease, but it does not guarantee that the person will definitely get the disease. Environmental factors, lifestyle choices, and interactions between genes also play crucial roles in determining if a genetically predisposed person will actually develop the disease. It is essential to understand that having a genetic predisposition only implies a higher risk, not an inevitable outcome.

An Eye Bank is an organization that collects, stores, and distributes donated human eyes for corneal transplantation and other ocular medical research purposes. The eye bank's primary function is to ensure the quality of the donated tissue and make it available for those in need of sight-restoring procedures.

The cornea, the clear front part of the eye, can be surgically transplanted from a deceased donor to a recipient with corneal damage or disease, thereby improving or restoring their vision. The eye bank's role includes obtaining consent for donation, retrieving the eyes from the donor, evaluating the tissue for suitability, preserving it properly, and then allocating it to surgeons for transplantation.

Eye banks follow strict medical guidelines and adhere to ethical standards to ensure the safety and quality of the donated tissues. The process involves screening potential donors for infectious diseases and other conditions that may affect the quality or safety of the cornea. Once deemed suitable, the corneas are carefully removed, preserved in specific solutions, and stored until they are needed for transplantation.

In addition to corneal transplants, eye banks also support research and education in ophthalmology by providing human eye tissues for various studies aimed at advancing our understanding of eye diseases and developing new treatments.

Eye color is a characteristic determined by variations in a person's genes. The color of the eyes depends on the amount and type of pigment called melanin found in the eye's iris.

There are three main types of eye colors: brown, blue, and green. Brown eyes have the most melanin, while blue eyes have the least. Green eyes have a moderate amount of melanin combined with a golden tint that reflects light to give them their unique color.

Eye color is a polygenic trait, which means it is influenced by multiple genes. The two main genes responsible for eye color are OCA2 and HERC2, both located on chromosome 15. These genes control the production, transport, and storage of melanin in the iris.

It's important to note that eye color can change during infancy and early childhood due to the development of melanin in the iris. Additionally, some medications or medical conditions may also cause changes in eye color over time.

The vitreous body, also known simply as the vitreous, is the clear, gel-like substance that fills the space between the lens and the retina in the eye. It is composed mainly of water, but also contains collagen fibers, hyaluronic acid, and other proteins. The vitreous helps to maintain the shape of the eye and provides a transparent medium for light to pass through to reach the retina. With age, the vitreous can become more liquefied and may eventually separate from the retina, leading to symptoms such as floaters or flashes of light.

Intraocular injections are a type of medical procedure where medication is administered directly into the eye. This technique is often used to deliver drugs that treat various eye conditions, such as age-related macular degeneration, diabetic retinopathy, and endophthalmitis. The most common type of intraocular injection is an intravitreal injection, which involves injecting medication into the vitreous cavity, the space inside the eye filled with a clear gel-like substance called the vitreous humor. This procedure is typically performed by an ophthalmologist in a clinical setting and may be repeated at regular intervals depending on the condition being treated.

Pyridinium compounds are organic salts that contain a positively charged pyridinium ion. Pyridinium is a type of cation that forms when pyridine, a basic heterocyclic organic compound, undergoes protonation. The nitrogen atom in the pyridine ring accepts a proton (H+) and becomes positively charged, forming the pyridinium ion.

Pyridinium compounds have the general structure of C5H5NH+X-, where X- is an anion or negatively charged ion. These compounds are often used in research and industry, including as catalysts, intermediates in chemical synthesis, and in pharmaceuticals. Some pyridinium compounds have been studied for their potential therapeutic uses, such as in the treatment of bacterial infections or cancer. However, it is important to note that some pyridinium compounds can also be toxic or reactive, so they must be handled with care.

A visual field test is a method used to measure an individual's entire scope of vision, which includes what can be seen straight ahead and in peripheral (or side) vision. During the test, the person being tested is asked to focus on a central point while gradually identifying the appearance of objects moving into their peripheral vision. The visual field test helps detect blind spots (scotomas) or gaps in the visual field, which can be caused by various conditions such as glaucoma, brain injury, optic nerve damage, or retinal disorders. It's an essential tool for diagnosing and monitoring eye-related diseases and conditions.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Diagnostic techniques in ophthalmology refer to the various methods and tests used by eye specialists (ophthalmologists) to examine, evaluate, and diagnose conditions related to the eyes and visual system. Here are some commonly used diagnostic techniques:

1. Visual Acuity Testing: This is a basic test to measure the sharpness of a person's vision. It typically involves reading letters or numbers from an eye chart at a specific distance.
2. Refraction Test: This test helps determine the correct lens prescription for glasses or contact lenses by measuring how light is bent as it passes through the cornea and lens.
3. Slit Lamp Examination: A slit lamp is a microscope that allows an ophthalmologist to examine the structures of the eye, including the cornea, iris, lens, and retina, in great detail.
4. Tonometry: This test measures the pressure inside the eye (intraocular pressure) to detect conditions like glaucoma. Common methods include applanation tonometry and non-contact tonometry.
5. Retinal Imaging: Several techniques are used to capture images of the retina, including fundus photography, fluorescein angiography, and optical coherence tomography (OCT). These tests help diagnose conditions like macular degeneration, diabetic retinopathy, and retinal detachments.
6. Color Vision Testing: This test evaluates a person's ability to distinguish between different colors, which can help detect color vision deficiencies or neurological disorders affecting the visual pathway.
7. Visual Field Testing: This test measures a person's peripheral (or side) vision and can help diagnose conditions like glaucoma, optic nerve damage, or brain injuries.
8. Pupillary Reactions Tests: These tests evaluate how the pupils respond to light and near objects, which can provide information about the condition of the eye's internal structures and the nervous system.
9. Ocular Motility Testing: This test assesses eye movements and alignment, helping diagnose conditions like strabismus (crossed eyes) or nystagmus (involuntary eye movement).
10. Corneal Topography: This non-invasive imaging technique maps the curvature of the cornea, which can help detect irregularities, assess the fit of contact lenses, and plan refractive surgery procedures.

The eye is the organ of sight, primarily responsible for detecting and focusing on visual stimuli. It is a complex structure composed of various parts that work together to enable vision. Here are some of the main components of the eye:

1. Cornea: The clear front part of the eye that refracts light entering the eye and protects the eye from harmful particles and microorganisms.
2. Iris: The colored part of the eye that controls the amount of light reaching the retina by adjusting the size of the pupil.
3. Pupil: The opening in the center of the iris that allows light to enter the eye.
4. Lens: A biconvex structure located behind the iris that further refracts light and focuses it onto the retina.
5. Retina: A layer of light-sensitive cells (rods and cones) at the back of the eye that convert light into electrical signals, which are then transmitted to the brain via the optic nerve.
6. Optic Nerve: The nerve that carries visual information from the retina to the brain.
7. Vitreous: A clear, gel-like substance that fills the space between the lens and the retina, providing structural support to the eye.
8. Conjunctiva: A thin, transparent membrane that covers the front of the eye and the inner surface of the eyelids.
9. Extraocular Muscles: Six muscles that control the movement of the eye, allowing for proper alignment and focus.

The eye is a remarkable organ that allows us to perceive and interact with our surroundings. Various medical specialties, such as ophthalmology and optometry, are dedicated to the diagnosis, treatment, and management of various eye conditions and diseases.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Optic atrophy is a medical term that refers to the degeneration and shrinkage (atrophy) of the optic nerve, which transmits visual information from the eye to the brain. This condition can result in various vision abnormalities, including loss of visual acuity, color vision deficiencies, and peripheral vision loss.

Optic atrophy can occur due to a variety of causes, such as:

* Traumatic injuries to the eye or optic nerve
* Glaucoma
* Optic neuritis (inflammation of the optic nerve)
* Ischemic optic neuropathy (reduced blood flow to the optic nerve)
* Compression or swelling of the optic nerve
* Hereditary or congenital conditions affecting the optic nerve
* Toxins and certain medications that can damage the optic nerve.

The diagnosis of optic atrophy typically involves a comprehensive eye examination, including visual acuity testing, refraction assessment, slit-lamp examination, and dilated funduscopic examination to evaluate the health of the optic nerve. In some cases, additional diagnostic tests such as visual field testing, optical coherence tomography (OCT), or magnetic resonance imaging (MRI) may be necessary to confirm the diagnosis and determine the underlying cause.

There is no specific treatment for optic atrophy, but addressing the underlying cause can help prevent further damage to the optic nerve. In some cases, vision rehabilitation may be recommended to help patients adapt to their visual impairment.

Photoreceptor cells are specialized neurons in the retina of the eye that convert light into electrical signals. These cells consist of two types: rods and cones. Rods are responsible for vision at low light levels and provide black-and-white, peripheral, and motion sensitivity. Cones are active at higher light levels and are capable of color discrimination and fine detail vision. Both types of photoreceptor cells contain light-sensitive pigments that undergo chemical changes when exposed to light, triggering a series of electrical signals that ultimately reach the brain and contribute to visual perception.

An intervertebral disc is a fibrocartilaginous structure found between the vertebrae of the spinal column in humans and other animals. It functions as a shock absorber, distributes mechanical stress during weight-bearing activities, and allows for varying degrees of mobility between adjacent vertebrae.

The disc is composed of two parts: the annulus fibrosus, which forms the tough, outer layer; and the nucleus pulposus, which is a gel-like substance in the center that contains proteoglycans and water. The combination of these components provides the disc with its unique ability to distribute forces and allow for movement.

The intervertebral discs are essential for the normal functioning of the spine, providing stability, flexibility, and protection to the spinal cord and nerves. However, they can also be subject to degeneration and injury, which may result in conditions such as herniated discs or degenerative disc disease.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Retinal vessels refer to the blood vessels that are located in the retina, which is the light-sensitive tissue that lines the inner surface of the eye. The retina contains two types of blood vessels: arteries and veins.

The central retinal artery supplies oxygenated blood to the inner layers of the retina, while the central retinal vein drains deoxygenated blood from the retina. These vessels can be visualized during a routine eye examination using an ophthalmoscope, which allows healthcare professionals to assess their health and any potential abnormalities.

Retinal vessels are essential for maintaining the health and function of the retina, and any damage or changes to these vessels can affect vision and lead to various eye conditions such as diabetic retinopathy, retinal vein occlusion, and hypertensive retinopathy.

Complement C3 is a protein that plays a central role in the complement system, which is a part of the immune system that helps to clear pathogens and damaged cells from the body. Complement C3 can be activated through three different pathways: the classical pathway, the lectin pathway, and the alternative pathway. Once activated, it breaks down into two fragments, C3a and C3b.

C3a is an anaphylatoxin that helps to recruit immune cells to the site of infection or injury, while C3b plays a role in opsonization, which is the process of coating pathogens or damaged cells with proteins to make them more recognizable to the immune system. Additionally, C3b can also activate the membrane attack complex (MAC), which forms a pore in the membrane of target cells leading to their lysis or destruction.

In summary, Complement C3 is an important protein in the complement system that helps to identify and eliminate pathogens and damaged cells from the body through various mechanisms.

A haplotype is a group of genes or DNA sequences that are inherited together from a single parent. It refers to a combination of alleles (variant forms of a gene) that are located on the same chromosome and are usually transmitted as a unit. Haplotypes can be useful in tracing genetic ancestry, understanding the genetic basis of diseases, and developing personalized medical treatments.

In population genetics, haplotypes are often used to study patterns of genetic variation within and between populations. By comparing haplotype frequencies across populations, researchers can infer historical events such as migrations, population expansions, and bottlenecks. Additionally, haplotypes can provide information about the evolutionary history of genes and genomic regions.

In clinical genetics, haplotypes can be used to identify genetic risk factors for diseases or to predict an individual's response to certain medications. For example, specific haplotypes in the HLA gene region have been associated with increased susceptibility to certain autoimmune diseases, while other haplotypes in the CYP450 gene family can affect how individuals metabolize drugs.

Overall, haplotypes provide a powerful tool for understanding the genetic basis of complex traits and diseases, as well as for developing personalized medical treatments based on an individual's genetic makeup.

Retinal cone photoreceptor cells are specialized neurons located in the retina of the eye, responsible for visual phototransduction and color vision. They are one of the two types of photoreceptors, with the other being rods, which are more sensitive to low light levels. Cones are primarily responsible for high-acuity, color vision during daylight or bright-light conditions.

There are three types of cone cells, each containing different photopigments that absorb light at distinct wavelengths: short (S), medium (M), and long (L) wavelengths, which correspond to blue, green, and red light, respectively. The combination of signals from these three types of cones allows the human visual system to perceive a wide range of colors and discriminate between them. Cones are densely packed in the central region of the retina, known as the fovea, which provides the highest visual acuity.

A laser is not a medical term per se, but a physical concept that has important applications in medicine. The term "LASER" stands for "Light Amplification by Stimulated Emission of Radiation." It refers to a device that produces and amplifies light with specific characteristics, such as monochromaticity (single wavelength), coherence (all waves moving in the same direction), and high intensity.

In medicine, lasers are used for various therapeutic and diagnostic purposes, including surgery, dermatology, ophthalmology, and dentistry. They can be used to cut, coagulate, or vaporize tissues with great precision, minimizing damage to surrounding structures. Additionally, lasers can be used to detect and measure physiological parameters, such as blood flow and oxygen saturation.

It's important to note that while lasers are powerful tools in medicine, they must be used by trained professionals to ensure safe and effective treatment.

Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) is a member of the tissue inhibitors of metalloproteinases (TIMPs) family, which are natural inhibitors of matrix metalloproteinases (MMPs), a group of enzymes involved in the degradation and remodeling of extracellular matrix components.

TIMP-3 is unique among TIMPs because it can inhibit all known MMPs and also has the ability to inhibit some members of the ADAM (a disintegrin and metalloproteinase) family, which are involved in protein ectodomain shedding and cell adhesion.

TIMP-3 is a secreted glycoprotein that binds to the extracellular matrix and regulates MMP activity locally. It has been shown to play important roles in various biological processes, including tissue remodeling, angiogenesis, inflammation, and apoptosis. Dysregulation of TIMP-3 expression or function has been implicated in several diseases, such as cancer, fibrosis, and neurodegenerative disorders.

Dark adaptation is the process by which the eyes adjust to low levels of light. This process allows the eyes to become more sensitive to light and see better in the dark. It involves the dilation of the pupils, as well as chemical changes in the rods and cones (photoreceptor cells) of the retina. These changes allow the eye to detect even small amounts of light and improve visual acuity in low-light conditions. Dark adaptation typically takes several minutes to occur fully, but can be faster or slower depending on various factors such as age, prior exposure to light, and certain medical conditions. It is an important process for maintaining good vision in a variety of lighting conditions.

An injection is a medical procedure in which a medication, vaccine, or other substance is introduced into the body using a needle and syringe. The substance can be delivered into various parts of the body, including into a vein (intravenous), muscle (intramuscular), under the skin (subcutaneous), or into the spinal canal (intrathecal or spinal).

Injections are commonly used to administer medications that cannot be taken orally, have poor oral bioavailability, need to reach the site of action quickly, or require direct delivery to a specific organ or tissue. They can also be used for diagnostic purposes, such as drawing blood samples (venipuncture) or injecting contrast agents for imaging studies.

Proper technique and sterile conditions are essential when administering injections to prevent infection, pain, and other complications. The choice of injection site depends on the type and volume of the substance being administered, as well as the patient's age, health status, and personal preferences.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Visual fields refer to the total area in which objects can be seen while keeping the eyes focused on a central point. It is the entire area that can be observed using peripheral (side) vision while the eye gazes at a fixed point. A visual field test is used to detect blind spots or gaps (scotomas) in a person's vision, which could indicate various medical conditions such as glaucoma, retinal damage, optic nerve disease, brain tumors, or strokes. The test measures both the central and peripheral vision and maps the entire area that can be seen when focusing on a single point.

Human chromosome pair 10 refers to a group of genetic materials that are present in every cell of the human body. Chromosomes are thread-like structures that carry our genes and are located in the nucleus of most cells. They come in pairs, with one set inherited from each parent.

Chromosome pair 10 is one of the 22 autosomal chromosome pairs, meaning they contain genes that are not related to sex determination. Each member of chromosome pair 10 is a single, long DNA molecule that contains thousands of genes and other genetic material.

Chromosome pair 10 is responsible for carrying genetic information that influences various traits and functions in the human body. Some of the genes located on chromosome pair 10 are associated with certain medical conditions, such as hereditary breast and ovarian cancer syndrome, neurofibromatosis type 1, and Waardenburg syndrome type 2A.

It's important to note that while chromosomes carry genetic information, not all variations in the DNA sequence will result in a change in phenotype or function. Some variations may have no effect at all, while others may lead to changes in how proteins are made and function, potentially leading to disease or other health issues.

Sensory aids are devices or equipment that are used to improve or compensate for impaired sensory functions such as hearing, vision, or touch. They are designed to help individuals with disabilities or impairments to better interact with their environment and perform daily activities. Here are some examples:

1. Hearing aids - electronic devices worn in or behind the ear that amplify sounds for people with hearing loss.
2. Cochlear implants - surgically implanted devices that provide sound sensations to individuals with severe to profound hearing loss.
3. Visual aids - devices used to improve vision, such as eyeglasses, contact lenses, magnifiers, or telescopic lenses.
4. Low vision devices - specialized equipment for people with significant visual impairment, including large print books, talking watches, and screen readers.
5. Tactile aids - devices that provide tactile feedback to individuals with visual or hearing impairments, such as Braille displays or vibrating pagers.

Overall, sensory aids play an essential role in enhancing the quality of life for people with sensory impairments by improving their ability to communicate, access information, and navigate their environment.

Aptamers are short, single-stranded oligonucleotides (DNA or RNA) that bind to specific target molecules with high affinity and specificity. They are generated through an iterative process called Systematic Evolution of Ligands by EXponential enrichment (SELEX), where large libraries of randomized oligonucleotides are subjected to repeated rounds of selection and amplification until sequences with the desired binding properties are identified. Nucleotide aptamers have potential applications in various fields, including diagnostics, therapeutics, and research tools.

The term "nucleotide" refers to the basic building blocks of nucleic acids (DNA and RNA). A nucleotide consists of a pentose sugar (ribose for RNA and deoxyribose for DNA), a phosphate group, and a nitrogenous base. The nitrogenous bases in nucleotides are adenine, guanine, cytosine, thymine (in DNA) or uracil (in RNA). In aptamers, the nucleotide sequences form specific three-dimensional structures that enable them to recognize and bind to their target molecules.

Complement activation is the process by which the complement system, a part of the immune system, is activated to help eliminate pathogens and damaged cells from the body. The complement system consists of a group of proteins that work together to recognize and destroy foreign substances.

Activation of the complement system can occur through three different pathways: the classical pathway, the lectin pathway, and the alternative pathway. Each pathway involves a series of proteolytic reactions that ultimately result in the formation of the membrane attack complex (MAC), which creates a pore in the membrane of the target cell, leading to its lysis and removal.

The classical pathway is typically activated by the binding of antibodies to antigens on the surface of a pathogen or damaged cell. The lectin pathway is activated by the recognition of specific carbohydrate structures on the surface of microorganisms. The alternative pathway can be spontaneously activated and serves as an amplification loop for both the classical and lectin pathways.

Complement activation plays a crucial role in the immune response, but uncontrolled or excessive activation can also lead to tissue damage and inflammation. Dysregulation of complement activation has been implicated in various diseases, including autoimmune disorders, inflammatory conditions, and neurodegenerative diseases.

Complement Factor I is a protein involved in the regulation of the complement system, which is a part of the immune system that helps to clear pathogens and damaged cells from the body. Specifically, Complement Factor I is a serine protease that regulates the complement component C3b by cleaving it into inactive fragments, thereby preventing the excessive activation of the complement system and protecting host tissues from damage.

Complement Factor I functions in conjunction with other regulatory proteins, such as complement receptor 1 (CR1) and membrane cofactor protein (MCP), to control the activity of the complement system at various stages. Deficiencies or mutations in Complement Factor I have been associated with several diseases, including atypical hemolytic uremic syndrome (aHUS), age-related macular degeneration (AMD), and systemic lupus erythematosus (SLE).

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Oxidative stress is defined as an imbalance between the production of reactive oxygen species (free radicals) and the body's ability to detoxify them or repair the damage they cause. This imbalance can lead to cellular damage, oxidation of proteins, lipids, and DNA, disruption of cellular functions, and activation of inflammatory responses. Prolonged or excessive oxidative stress has been linked to various health conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and aging-related diseases.

I'm sorry for any confusion, but "reading" is not a term that has a specific medical definition. Reading is the activity or process of deciphering and understanding written words or text. It is a fundamental skill in language acquisition and communication, and is not typically used in a medical context unless there is a concern related to reading difficulties or disorders, such as dyslexia. If you have any questions related to medical terminology or health concerns, I'd be happy to try to help answer those for you!

Retinoschisis is a medical term that refers to a specific eye condition where there is a separation (schisis) of the retinal layers, particularly the neurosensory retina. This condition often affects the peripheral retina and can be classified as congenital or acquired. Congenital retinoschisis is usually present at birth or develops during early childhood, while acquired retinoschisis occurs later in life due to various reasons such as trauma, inflammation, or degenerative changes.

In retinoschisis, the inner layers of the retina split apart, creating a cavity filled with fluid. This separation can lead to visual symptoms like blurred vision, shadows, or blind spots in the affected area of the visual field. However, it is important to note that many cases of retinoschisis do not cause significant visual impairment and may only require monitoring by an eye care professional.

Retinoschisis can be diagnosed through a comprehensive eye examination, including a dilated fundus exam, which allows the eye care professional to examine the retina thoroughly. In some cases, additional diagnostic tests like optical coherence tomography (OCT) or fluorescein angiography may be used to confirm the diagnosis and assess the extent of the condition.

Treatment for retinoschisis depends on the severity and location of the separation. Mild cases may not require any treatment, while more severe cases may need surgical intervention to prevent complications such as retinal detachment or bleeding in the eye. Regular follow-up appointments with an eye care professional are essential to monitor the condition and ensure appropriate management.

Retrograde degeneration is a medical term that refers to the process of degeneration or damage in neurons (nerve cells) that occurs backward from the site of injury or disease along the axon, which is the part of the neuron that transmits electrical signals to other neurons. This can lead to functional loss and may eventually result in the death of the neuron. Retrograde degeneration is often seen in neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's disease, as well as in spinal cord injuries.

An allele is a variant form of a gene that is located at a specific position on a specific chromosome. Alleles are alternative forms of the same gene that arise by mutation and are found at the same locus or position on homologous chromosomes.

Each person typically inherits two copies of each gene, one from each parent. If the two alleles are identical, a person is said to be homozygous for that trait. If the alleles are different, the person is heterozygous.

For example, the ABO blood group system has three alleles, A, B, and O, which determine a person's blood type. If a person inherits two A alleles, they will have type A blood; if they inherit one A and one B allele, they will have type AB blood; if they inherit two B alleles, they will have type B blood; and if they inherit two O alleles, they will have type O blood.

Alleles can also influence traits such as eye color, hair color, height, and other physical characteristics. Some alleles are dominant, meaning that only one copy of the allele is needed to express the trait, while others are recessive, meaning that two copies of the allele are needed to express the trait.

Medical definitions for visual impairment often vary, but according to the World Health Organization (WHO), visually impaired persons are those who have a best-corrected visual acuity of less than 0.3 (6/12) in their better eye or a visual field of less than 20 degrees in their better eye. This includes people who are blind, as well as those with partial sight.

Visual impairment can range from mild to severe and may result from a variety of causes, including genetic disorders, diseases, trauma, or aging. It is important to note that visual impairment does not necessarily mean total blindness; many visually impaired individuals have some remaining vision and can benefit from low vision services and assistive devices.

Retinal rod photoreceptor cells are specialized neurons in the retina of the eye that are primarily responsible for vision in low light conditions. They contain a light-sensitive pigment called rhodopsin, which undergoes a chemical change when struck by a single photon of light. This triggers a cascade of biochemical reactions that ultimately leads to the generation of electrical signals, which are then transmitted to the brain via the optic nerve.

Rod cells do not provide color vision or fine detail, but they allow us to detect motion and see in dim light. They are more sensitive to light than cone cells, which are responsible for color vision and detailed sight in bright light conditions. Rod cells are concentrated at the outer edges of the retina, forming a crescent-shaped region called the peripheral retina, with fewer rod cells located in the central region of the retina known as the fovea.

The alternative complement pathway is one of the three initiating pathways of the complement system, which is a part of the innate immune system that helps to clear pathogens and damaged cells from the body. The other two pathways are the classical and lectin pathways.

The alternative pathway is continuously activated at a low level, even in the absence of infection or injury, through the spontaneous cleavage of complement component C3 into C3a and C3b by the protease factor D in the presence of magnesium ions. The generated C3b can then bind covalently to nearby surfaces, including pathogens and host cells.

On self-surfaces, regulatory proteins like decay-accelerating factor (DAF) or complement receptor 1 (CR1) help to prevent the formation of the alternative pathway convertase and thus further activation of the complement system. However, on foreign surfaces, the C3b can recruit more complement components, forming a complex called the alternative pathway convertase (C3bBb), which cleaves additional C3 molecules into C3a and C3b.

The generated C3b can then bind to the surface and participate in the formation of the membrane attack complex (MAC), leading to the lysis of the target cell. The alternative pathway plays a crucial role in the defense against gram-negative bacteria, fungi, and parasites, as well as in the clearance of immune complexes and apoptotic cells. Dysregulation of the alternative complement pathway has been implicated in several diseases, including autoimmune disorders and atypical hemolytic uremic syndrome (aHUS).

Complement C3b inactivator proteins, also known as complement regulators or decay-accelerating factor (DAF), are a group of proteins that play a crucial role in regulating the complement system. The complement system is a part of the immune system that helps to eliminate pathogens and damaged cells from the body.

The complement C3b inactivator proteins include two main types: complement receptor 1 (CR1) and decay-accelerating factor (DAF). These proteins work by regulating the formation of the membrane attack complex (MAC), a protein structure that forms pores in the cell membrane, leading to cell lysis.

Complement C3b inactivator proteins bind to C3b and C4b components of the complement system, preventing them from forming the MAC. By doing so, they help to prevent excessive activation of the complement system, which can damage healthy cells and tissues.

Deficiencies or dysfunction of complement C3b inactivator proteins have been associated with several diseases, including autoimmune disorders, inflammatory diseases, and infectious diseases. Therefore, understanding the role of these proteins in regulating the complement system is essential for developing new therapies to treat these conditions.

Contrast sensitivity is a measure of the ability to distinguish between an object and its background based on differences in contrast, rather than differences in luminance. Contrast refers to the difference in light intensity between an object and its immediate surroundings. Contrast sensitivity is typically measured using specially designed charts that have patterns of parallel lines with varying widths and contrast levels.

In clinical settings, contrast sensitivity is often assessed as part of a comprehensive visual examination. Poor contrast sensitivity can affect a person's ability to perform tasks such as reading, driving, or distinguishing objects from their background, especially in low-light conditions. Reduced contrast sensitivity is a common symptom of various eye conditions, including cataracts, glaucoma, and age-related macular degeneration.

Glaucoma is a group of eye conditions that damage the optic nerve, often caused by an abnormally high pressure in the eye (intraocular pressure). This damage can lead to permanent vision loss or even blindness if left untreated. The most common type is open-angle glaucoma, which has no warning signs and progresses slowly. Angle-closure glaucoma, on the other hand, can cause sudden eye pain, redness, nausea, and vomiting, as well as rapid vision loss. Other less common types of glaucoma also exist. While there is no cure for glaucoma, early detection and treatment can help slow or prevent further vision loss.

In the context of medical terminology, "light" doesn't have a specific or standardized definition on its own. However, it can be used in various medical terms and phrases. For example, it could refer to:

1. Visible light: The range of electromagnetic radiation that can be detected by the human eye, typically between wavelengths of 400-700 nanometers. This is relevant in fields such as ophthalmology and optometry.
2. Therapeutic use of light: In some therapies, light is used to treat certain conditions. An example is phototherapy, which uses various wavelengths of ultraviolet (UV) or visible light for conditions like newborn jaundice, skin disorders, or seasonal affective disorder.
3. Light anesthesia: A state of reduced consciousness in which the patient remains responsive to verbal commands and physical stimulation. This is different from general anesthesia where the patient is completely unconscious.
4. Pain relief using light: Certain devices like transcutaneous electrical nerve stimulation (TENS) units have a 'light' setting, indicating lower intensity or frequency of electrical impulses used for pain management.

Without more context, it's hard to provide a precise medical definition of 'light'.

Serine endopeptidases are a type of enzymes that cleave peptide bonds within proteins (endopeptidases) and utilize serine as the nucleophilic amino acid in their active site for catalysis. These enzymes play crucial roles in various biological processes, including digestion, blood coagulation, and programmed cell death (apoptosis). Examples of serine endopeptidases include trypsin, chymotrypsin, thrombin, and elastase.

Gene frequency, also known as allele frequency, is a measure in population genetics that reflects the proportion of a particular gene or allele (variant of a gene) in a given population. It is calculated as the number of copies of a specific allele divided by the total number of all alleles at that genetic locus in the population.

For example, if we consider a gene with two possible alleles, A and a, the gene frequency of allele A (denoted as p) can be calculated as follows:

p = (number of copies of allele A) / (total number of all alleles at that locus)

Similarly, the gene frequency of allele a (denoted as q) would be:

q = (number of copies of allele a) / (total number of all alleles at that locus)

Since there are only two possible alleles for this gene in this example, p + q = 1. These frequencies can help researchers understand genetic diversity and evolutionary processes within populations.

Rhodopsin, also known as visual purple, is a light-sensitive pigment found in the rods of the vertebrate retina. It is a complex protein molecule made up of two major components: an opsin protein and retinal, a form of vitamin A. When light hits the retinal in rhodopsin, it changes shape, which initiates a series of chemical reactions leading to the activation of the visual pathway and ultimately results in vision. This process is known as phototransduction. Rhodopsin plays a crucial role in low-light vision or scotopic vision.

Ophthalmology is a branch of medicine that deals with the diagnosis, treatment, and prevention of diseases and disorders of the eye and visual system. It is a surgical specialty, and ophthalmologists are medical doctors who complete additional years of training to become experts in eye care. They are qualified to perform eye exams, diagnose and treat eye diseases, prescribe glasses and contact lenses, and perform eye surgery. Some subspecialties within ophthalmology include cornea and external disease, glaucoma, neuro-ophthalmology, pediatric ophthalmology, retina and vitreous, and oculoplastics.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Spinocerebellar degenerations (SCDs) are a group of genetic disorders that primarily affect the cerebellum, the part of the brain responsible for coordinating muscle movements, and the spinal cord. These conditions are characterized by progressive degeneration or loss of nerve cells in the cerebellum and/or spinal cord, leading to various neurological symptoms.

SCDs are often inherited in an autosomal dominant manner, meaning that only one copy of the altered gene from either parent is enough to cause the disorder. The most common type of SCD is spinocerebellar ataxia (SCA), which includes several subtypes (SCA1, SCA2, SCA3, etc.) differentiated by their genetic causes and specific clinical features.

Symptoms of spinocerebellar degenerations may include:

1. Progressive ataxia (loss of coordination and balance)
2. Dysarthria (speech difficulty)
3. Nystagmus (involuntary eye movements)
4. Oculomotor abnormalities (problems with eye movement control)
5. Tremors or other involuntary muscle movements
6. Muscle weakness and spasticity
7. Sensory disturbances, such as numbness or tingling sensations
8. Dysphagia (difficulty swallowing)
9. Cognitive impairment in some cases

The age of onset, severity, and progression of symptoms can vary significantly among different SCD subtypes and individuals. Currently, there is no cure for spinocerebellar degenerations, but various supportive treatments and therapies can help manage symptoms and improve quality of life.

Linkage disequilibrium (LD) is a term used in genetics that refers to the non-random association of alleles at different loci (genetic locations) on a chromosome. This means that certain combinations of genetic variants, or alleles, at different loci occur more frequently together in a population than would be expected by chance.

Linkage disequilibrium can arise due to various factors such as genetic drift, selection, mutation, and population structure. It is often used in the context of genetic mapping studies to identify regions of the genome that are associated with particular traits or diseases. High levels of LD in a region of the genome suggest that the loci within that region are in linkage, meaning they tend to be inherited together.

The degree of LD between two loci can be measured using various statistical methods, such as D' and r-squared. These measures provide information about the strength and direction of the association between alleles at different loci, which can help researchers identify causal genetic variants underlying complex traits or diseases.

The Fluorescent Antibody Technique (FAT), Indirect is a type of immunofluorescence assay used to detect the presence of specific antigens in a sample. In this method, the sample is first incubated with a primary antibody that binds to the target antigen. After washing to remove unbound primary antibodies, a secondary fluorescently labeled antibody is added, which recognizes and binds to the primary antibody. This indirect labeling approach allows for amplification of the signal, making it more sensitive than direct methods. The sample is then examined under a fluorescence microscope to visualize the location and amount of antigen based on the emitted light from the fluorescent secondary antibody. It's commonly used in diagnostic laboratories for detection of various bacteria, viruses, and other antigens in clinical specimens.

Triamcinolone is a glucocorticoid medication, which is a class of corticosteroids. It is used to treat various inflammatory and autoimmune conditions due to its anti-inflammatory and immunosuppressive effects. Triamcinolone is available in several forms, including topical creams, ointments, and lotions for skin application; oral tablets and injectable solutions for systemic use; and inhaled preparations for the treatment of asthma and other respiratory conditions.

Triamcinolone works by binding to specific receptors in cells, which leads to a decrease in the production of inflammatory chemicals such as prostaglandins and leukotrienes. This results in reduced swelling, redness, itching, and pain associated with inflammation.

Some common uses of triamcinolone include treating skin conditions like eczema, psoriasis, and dermatitis; managing allergic reactions; reducing inflammation in respiratory diseases like asthma and COPD; and alleviating symptoms of rheumatoid arthritis and other autoimmune disorders.

As with any medication, triamcinolone can have side effects, especially when used in high doses or for extended periods. Common side effects include increased appetite, weight gain, mood changes, insomnia, acne, thinning of the skin, and easy bruising. Long-term use may also lead to more serious complications such as osteoporosis, adrenal suppression, and increased susceptibility to infections. It is essential to follow your healthcare provider's instructions carefully when using triamcinolone or any other prescription medication.

Peripherins are a family of neuron-specific type III intermediate filament proteins that are expressed in the peripheral nervous system. They play crucial roles in maintaining the structural integrity and stability of nerve cells, particularly during development and regeneration. Peripherins have also been implicated in various neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth disease (CMT). There are several isoforms of peripherins, with peripherin 2 being the most widely studied. Mutations in the gene encoding peripherin 2 have been linked to certain forms of CMT.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

Diabetic retinopathy is a diabetes complication that affects the eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).

At first, diabetic retinopathy may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition usually affects both eyes.

There are two main stages of diabetic retinopathy:

1. Early diabetic retinopathy. This is when the blood vessels in the eye start to leak fluid or bleed. You might not notice any changes in your vision at this stage, but it's still important to get treatment because it can prevent the condition from getting worse.
2. Advanced diabetic retinopathy. This is when new, abnormal blood vessels grow on the surface of the retina. These vessels can leak fluid and cause severe vision problems, including blindness.

Diabetic retinopathy can be treated with laser surgery, injections of medication into the eye, or a vitrectomy (a surgical procedure to remove the gel-like substance that fills the center of the eye). It's important to get regular eye exams to detect diabetic retinopathy early and get treatment before it causes serious vision problems.

Triamcinolone Acetonide is a synthetic glucocorticoid, which is a class of corticosteroids. It is used in the form of topical creams, ointments, and sprays to reduce skin inflammation, itching, and allergies. It can also be administered through injection for the treatment of various conditions such as arthritis, bursitis, and tendonitis. Triamcinolone Acetonide works by suppressing the immune system's response, reducing inflammation, and blocking the production of substances that cause allergies.

It is important to note that prolonged use or overuse of triamcinolone acetonide can lead to side effects such as thinning of the skin, easy bruising, and increased susceptibility to infections. Therefore, it should be used under the guidance of a healthcare professional.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Coloring agents, also known as food dyes or color additives, are substances that are added to foods, medications, and cosmetics to improve their appearance by giving them a specific color. These agents can be made from both synthetic and natural sources. They must be approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA) before they can be used in products intended for human consumption.

Coloring agents are used for various reasons, including:

* To replace color lost during food processing or preparation
* To make foods more visually appealing
* To help consumers easily identify certain types of food
* To indicate the flavor of a product (e.g., fruit-flavored candies)

It's important to note that while coloring agents can enhance the appearance of products, they do not affect their taste or nutritional value. Some people may have allergic reactions to certain coloring agents, so it's essential to check product labels if you have any known allergies. Additionally, excessive consumption of some synthetic coloring agents has been linked to health concerns, so moderation is key.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

Ocular vision refers to the ability to process and interpret visual information that is received by the eyes. This includes the ability to see clearly and make sense of the shapes, colors, and movements of objects in the environment. The ocular system, which includes the eye and related structures such as the optic nerve and visual cortex of the brain, works together to enable vision.

There are several components of ocular vision, including:

* Visual acuity: the clarity or sharpness of vision
* Field of vision: the extent of the visual world that is visible at any given moment
* Color vision: the ability to distinguish different colors
* Depth perception: the ability to judge the distance of objects in three-dimensional space
* Contrast sensitivity: the ability to distinguish an object from its background based on differences in contrast

Disorders of ocular vision can include refractive errors such as nearsightedness or farsightedness, as well as more serious conditions such as cataracts, glaucoma, and macular degeneration. These conditions can affect one or more aspects of ocular vision and may require medical treatment to prevent further vision loss.

An ophthalmoscope is a medical device used by healthcare professionals to examine the interior structures of the eye, including the retina, optic disc, and vitreous humor. It consists of a handle with a battery-powered light source and a head that contains lenses for focusing. When placed in contact with the patient's dilated pupil, the ophthalmoscope allows the examiner to visualize the internal structures of the eye and assess their health. Ophthalmoscopes are commonly used in routine eye examinations, as well as in the diagnosis and management of various eye conditions and diseases.

Proteins are complex, large molecules that play critical roles in the body's functions. They are made up of amino acids, which are organic compounds that are the building blocks of proteins. Proteins are required for the structure, function, and regulation of the body's tissues and organs. They are essential for the growth, repair, and maintenance of body tissues, and they play a crucial role in many biological processes, including metabolism, immune response, and cellular signaling. Proteins can be classified into different types based on their structure and function, such as enzymes, hormones, antibodies, and structural proteins. They are found in various foods, especially animal-derived products like meat, dairy, and eggs, as well as plant-based sources like beans, nuts, and grains.

Cis-trans isomeres are molecules that have the same molecular formula and skeletal structure, but differ in the arrangement of their atoms around a double bond. In a cis isomer, the two larger groups or atoms are on the same side of the double bond, while in a trans isomer, they are on opposite sides.

Cis-trans isomerases are enzymes that catalyze the interconversion between cis and trans isomers of various molecules, such as fatty acids, steroids, and retinals. These enzymes play important roles in various biological processes, including membrane fluidity, vision, and the biosynthesis of hormones and other signaling molecules.

Examples of cis-trans isomerases include:

* Fatty acid desaturases, which introduce double bonds into fatty acids and can convert trans isomers to cis isomers
* Retinal isomerases, which interconvert the cis and trans isomers of retinal, a molecule involved in vision
* Steroid isomerases, which catalyze the interconversion of various steroids, including cholesterol and its derivatives.

Ophthalmologic surgical procedures refer to various types of surgeries performed on the eye and its surrounding structures by trained medical professionals called ophthalmologists. These procedures aim to correct or improve vision, diagnose and treat eye diseases or injuries, and enhance the overall health and functionality of the eye. Some common examples of ophthalmologic surgical procedures include:

1. Cataract Surgery: This procedure involves removing a cloudy lens (cataract) from the eye and replacing it with an artificial intraocular lens (IOL).
2. LASIK (Laser-Assisted In Situ Keratomileusis): A type of refractive surgery that uses a laser to reshape the cornea, correcting nearsightedness, farsightedness, and astigmatism.
3. Glaucoma Surgery: Several surgical options are available for treating glaucoma, including laser trabeculoplasty, traditional trabeculectomy, and various drainage device implantations. These procedures aim to reduce intraocular pressure (IOP) and prevent further optic nerve damage.
4. Corneal Transplant: This procedure involves replacing a damaged or diseased cornea with a healthy donor cornea to restore vision and improve the eye's appearance.
5. Vitreoretinal Surgery: These procedures focus on treating issues within the vitreous humor (gel-like substance filling the eye) and the retina, such as retinal detachment, macular holes, or diabetic retinopathy.
6. Strabismus Surgery: This procedure aims to correct misalignment of the eyes (strabismus) by adjusting the muscles responsible for eye movement.
7. Oculoplastic Surgery: These procedures involve reconstructive, cosmetic, and functional surgeries around the eye, such as eyelid repair, removal of tumors, or orbital fracture repairs.
8. Pediatric Ophthalmologic Procedures: Various surgical interventions are performed on children to treat conditions like congenital cataracts, amblyopia (lazy eye), or blocked tear ducts.

These are just a few examples of ophthalmic surgical procedures. The specific treatment plan will depend on the individual's condition and overall health.

Angiomatosis is a medical term that refers to a benign condition characterized by the proliferation of blood vessels in various tissues and organs. It is typically composed of small, tangled blood vessels called capillaries, which can form clusters or networks. The condition can affect skin, internal organs, bones, and other tissues.

Angiomatosis is often asymptomatic and may be discovered incidentally during medical imaging or surgical procedures. In some cases, it may cause symptoms such as pain, swelling, or bleeding, depending on the location and extent of the lesions.

While angiomatosis is generally a benign condition, in rare cases, it can be associated with malignant tumors or other medical conditions. Treatment options for angiomatosis depend on the size, location, and symptoms of the lesions and may include observation, medication, or surgical removal.

Antioxidants are substances that can prevent or slow damage to cells caused by free radicals, which are unstable molecules that the body produces as a reaction to environmental and other pressures. Antioxidants are able to neutralize free radicals by donating an electron to them, thus stabilizing them and preventing them from causing further damage to the cells.

Antioxidants can be found in a variety of foods, including fruits, vegetables, nuts, and grains. Some common antioxidants include vitamins C and E, beta-carotene, and selenium. Antioxidants are also available as dietary supplements.

In addition to their role in protecting cells from damage, antioxidants have been studied for their potential to prevent or treat a number of health conditions, including cancer, heart disease, and age-related macular degeneration. However, more research is needed to fully understand the potential benefits and risks of using antioxidant supplements.

Pathologic neovascularization is the abnormal growth of new blood vessels in previously avascular tissue or excessive growth within existing vasculature, which occurs as a result of hypoxia, inflammation, or angiogenic stimuli. These newly formed vessels are often disorganized, fragile, and lack proper vessel hierarchy, leading to impaired blood flow and increased vascular permeability. Pathologic neovascularization can be observed in various diseases such as cancer, diabetic retinopathy, age-related macular degeneration, and chronic inflammation. This process contributes to disease progression by promoting tumor growth, metastasis, and edema formation, ultimately leading to tissue damage and organ dysfunction.

ATP-binding cassette (ABC) transporters are a family of membrane proteins that utilize the energy from ATP hydrolysis to transport various substrates across extra- and intracellular membranes. These transporters play crucial roles in several biological processes, including detoxification, drug resistance, nutrient uptake, and regulation of cellular cholesterol homeostasis.

The structure of ABC transporters consists of two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP, and two transmembrane domains (TMDs) that form the substrate-translocation pathway. The NBDs are typically located adjacent to each other in the cytoplasm, while the TMDs can be either integral membrane domains or separate structures associated with the membrane.

The human genome encodes 48 distinct ABC transporters, which are classified into seven subfamilies (ABCA-ABCG) based on their sequence similarity and domain organization. Some well-known examples of ABC transporters include P-glycoprotein (ABCB1), multidrug resistance protein 1 (ABCC1), and breast cancer resistance protein (ABCG2).

Dysregulation or mutations in ABC transporters have been implicated in various diseases, such as cystic fibrosis, neurological disorders, and cancer. In cancer, overexpression of certain ABC transporters can contribute to drug resistance by actively effluxing chemotherapeutic agents from cancer cells, making them less susceptible to treatment.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Retinal neurons are the specialized nerve cells located in the retina, which is the light-sensitive tissue that lines the inner surface of the eye. The retina converts incoming light into electrical signals, which are then transmitted to the brain and interpreted as visual images. There are several types of retinal neurons, including:

1. Photoreceptors (rods and cones): These are the primary sensory cells that convert light into electrical signals. Rods are responsible for low-light vision, while cones are responsible for color vision and fine detail.
2. Bipolar cells: These neurons receive input from photoreceptors and transmit signals to ganglion cells. They can be either ON or OFF bipolar cells, depending on whether they respond to an increase or decrease in light intensity.
3. Ganglion cells: These are the output neurons of the retina that send visual information to the brain via the optic nerve. There are several types of ganglion cells, including parasol, midget, and small bistratified cells, which have different functions in processing visual information.
4. Horizontal cells: These interneurons connect photoreceptors to each other and help regulate the sensitivity of the retina to light.
5. Amacrine cells: These interneurons connect bipolar cells to ganglion cells and play a role in modulating the signals that are transmitted to the brain.

Overall, retinal neurons work together to process visual information and transmit it to the brain for further analysis and interpretation.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

Cataract extraction is a surgical procedure that involves removing the cloudy lens (cataract) from the eye. This procedure is typically performed to restore vision impairment caused by cataracts and improve overall quality of life. There are two primary methods for cataract extraction:

1. Phacoemulsification: This is the most common method used today. It involves making a small incision in the front part of the eye (cornea), inserting an ultrasonic probe to break up the cloudy lens into tiny pieces, and then removing those pieces with suction. After removing the cataract, an artificial intraocular lens (IOL) is inserted to replace the natural lens and help focus light onto the retina.

2. Extracapsular Cataract Extraction: In this method, a larger incision is made on the side of the cornea, allowing the surgeon to remove the cloudy lens in one piece without breaking it up. The back part of the lens capsule is left intact to support the IOL. This technique is less common and typically reserved for more advanced cataracts or when phacoemulsification cannot be performed.

Recovery from cataract extraction usually involves using eye drops to prevent infection and inflammation, as well as protecting the eye with a shield or glasses during sleep for a few weeks after surgery. Most people experience improved vision within a few days to a week following the procedure.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

The odds ratio (OR) is a statistical measure used in epidemiology and research to estimate the association between an exposure and an outcome. It represents the odds that an event will occur in one group versus the odds that it will occur in another group, assuming that all other factors are held constant.

In medical research, the odds ratio is often used to quantify the strength of the relationship between a risk factor (exposure) and a disease outcome. An OR of 1 indicates no association between the exposure and the outcome, while an OR greater than 1 suggests that there is a positive association between the two. Conversely, an OR less than 1 implies a negative association.

It's important to note that the odds ratio is not the same as the relative risk (RR), which compares the incidence rates of an outcome in two groups. While the OR can approximate the RR when the outcome is rare, they are not interchangeable and can lead to different conclusions about the association between an exposure and an outcome.

The Complement Membrane Attack Complex (MAC), also known as the Terminal Complement Complex (TCC), is a protein structure that forms in the final stages of the complement system's immune response. The complement system is a part of the innate immune system that helps to eliminate pathogens and damaged cells from the body.

The MAC is composed of several proteins, including C5b, C6, C7, C8, and multiple subunits of C9, which assemble on the surface of target cells. The formation of the MAC creates a pore-like structure in the cell membrane, leading to disruption of the membrane's integrity and ultimately causing cell lysis or damage.

The MAC plays an important role in the immune response by helping to eliminate pathogens that have evaded other immune defenses. However, uncontrolled activation of the complement system and formation of the MAC can also contribute to tissue damage and inflammation in various diseases, such as autoimmune disorders, age-related macular degeneration, and ischemia-reperfusion injury.

I'm sorry for any confusion, but "Wisconsin" is a U.S. state located in the Midwest and is not a medical term or condition. If you have any medical questions or terms you would like defined, I'd be happy to help with those!

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

An axon is a long, slender extension of a neuron (a type of nerve cell) that conducts electrical impulses (nerve impulses) away from the cell body to target cells, such as other neurons or muscle cells. Axons can vary in length from a few micrometers to over a meter long and are typically surrounded by a myelin sheath, which helps to insulate and protect the axon and allows for faster transmission of nerve impulses.

Axons play a critical role in the functioning of the nervous system, as they provide the means by which neurons communicate with one another and with other cells in the body. Damage to axons can result in serious neurological problems, such as those seen in spinal cord injuries or neurodegenerative diseases like multiple sclerosis.

A homozygote is an individual who has inherited the same allele (version of a gene) from both parents and therefore possesses two identical copies of that allele at a specific genetic locus. This can result in either having two dominant alleles (homozygous dominant) or two recessive alleles (homozygous recessive). In contrast, a heterozygote has inherited different alleles from each parent for a particular gene.

The term "homozygote" is used in genetics to describe the genetic makeup of an individual at a specific locus on their chromosomes. Homozygosity can play a significant role in determining an individual's phenotype (observable traits), as having two identical alleles can strengthen the expression of certain characteristics compared to having just one dominant and one recessive allele.

Beta-carotene is a type of carotenoid, which is a pigment found in plants that gives them their vibrant colors. It is commonly found in fruits and vegetables, such as carrots, sweet potatoes, and spinach.

Beta-carotene is converted into vitamin A in the body, which is an essential nutrient for maintaining healthy vision, immune function, and cell growth. It acts as an antioxidant, helping to protect cells from damage caused by free radicals.

According to the medical definition, beta-carotene is a provitamin A carotenoid that is converted into vitamin A in the body. It has a variety of health benefits, including supporting eye health, boosting the immune system, and reducing the risk of certain types of cancer. However, it is important to note that excessive consumption of beta-carotene supplements can lead to a condition called carotenemia, which causes the skin to turn yellow or orange.

Complement Factor D is a protein that plays a crucial role in the complement system, which is a part of the immune system that helps to clear pathogens and damaged cells from the body. Specifically, Factor D is a serine protease that is involved in the alternative pathway of the complement system.

In this pathway, Factor D helps to cleave another protein called Factor B, which then activates a complex called the C3 convertase. The C3 convertase cleaves complement component 3 (C3) into C3a and C3b, leading to the formation of the membrane attack complex (MAC), which creates a pore in the membrane of the target cell, causing its lysis and removal from the body.

Deficiencies or mutations in Complement Factor D can lead to an impaired alternative pathway and increased susceptibility to certain infections, particularly those caused by Neisseria bacteria. Additionally, abnormal regulation of the complement system has been implicated in a variety of diseases, including autoimmune disorders, inflammatory conditions, and neurodegenerative diseases.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Complement C1 Inactivator proteins are a part of the complement system, which is a group of proteins in the blood that play a crucial role in the body's immune defense system. Specifically, Complement C1 Inactivator proteins are responsible for regulating the activation of the first component of the complement system, C1.

The complement system is activated in response to the presence of foreign substances such as bacteria or viruses in the body. The activation of C1 leads to a cascade of reactions that result in the destruction of the foreign substance. However, if this process is not properly regulated, it can lead to damage to the body's own cells and tissues.

Complement C1 Inactivator proteins help to prevent this by regulating the activation of C1. They do this by binding to and inhibiting the activity of C1, preventing it from initiating the complement cascade. A deficiency in Complement C1 Inactivator proteins can lead to a condition called hereditary angioedema, which is characterized by recurrent episodes of swelling in various parts of the body.

The term "Asian Continental Ancestry Group" is a medical/ethnic classification used to describe a person's genetic background and ancestry. According to this categorization, individuals with origins in the Asian continent are grouped together. This includes populations from regions such as East Asia (e.g., China, Japan, Korea), South Asia (e.g., India, Pakistan, Bangladesh), Southeast Asia (e.g., Philippines, Indonesia, Thailand), and Central Asia (e.g., Kazakhstan, Uzbekistan, Tajikistan). It is important to note that this broad categorization may not fully capture the genetic diversity within these regions or accurately reflect an individual's specific ancestral origins.

Retinal dystrophies are a group of genetic eye disorders that primarily affect the retina, a light-sensitive layer at the back of the eye. These conditions are characterized by progressive degeneration and death of photoreceptor cells (rods and cones) in the retina, leading to vision loss.

The term "dystrophy" refers to a condition that results from the abnormal or defective development and function of tissues or organs. In the case of retinal dystrophies, the photoreceptor cells do not develop or function properly, resulting in visual impairment.

Retinal dystrophies can present at any age, from infancy to adulthood, and can have varying degrees of severity. Some common symptoms include night blindness, decreased visual acuity, loss of peripheral vision, light sensitivity, and color vision abnormalities.

Examples of retinal dystrophies include retinitis pigmentosa, Stargardt disease, Usher syndrome, and Leber congenital amaurosis, among others. These conditions are typically inherited and can be caused by mutations in various genes that play a role in the development and function of the retina.

There is currently no cure for retinal dystrophies, but research is ongoing to develop treatments that may slow or halt the progression of these conditions, such as gene therapy and stem cell transplantation.

The inner segment of a retinal photoreceptor cell, also known as the inner segment of a rod or cone cell, is the portion of the cell that contains the majority of its metabolic and energy-generating components. It is responsible for providing the energy needed for the outer segment, which is the part of the cell that contains the visual pigments and is responsible for phototransduction, or the conversion of light into electrical signals.

The inner segment is divided into two main parts: the ellipsoid and the myoid. The ellipsoid contains a high concentration of mitochondria, which provide energy to the cell through the process of oxidative phosphorylation. The myoid contains the endoplasmic reticulum and the Golgi apparatus, which are involved in protein synthesis and transport.

Damage to the inner segment of the retinal photoreceptor cells can lead to vision loss or impairment, as it can affect the ability of the outer segment to function properly and transmit visual signals to the brain.

Fluorescence is not a medical term per se, but it is widely used in the medical field, particularly in diagnostic tests, medical devices, and research. Fluorescence is a physical phenomenon where a substance absorbs light at a specific wavelength and then emits light at a longer wavelength. This process, often referred to as fluorescing, results in the emission of visible light that can be detected and measured.

In medical terms, fluorescence is used in various applications such as:

1. In-vivo imaging: Fluorescent dyes or probes are introduced into the body to highlight specific structures, cells, or molecules during imaging procedures. This technique can help doctors detect and diagnose diseases such as cancer, inflammation, or infection.
2. Microscopy: Fluorescence microscopy is a powerful tool for visualizing biological samples at the cellular and molecular level. By labeling specific proteins, nucleic acids, or other molecules with fluorescent dyes, researchers can observe their distribution, interactions, and dynamics within cells and tissues.
3. Surgical guidance: Fluorescence-guided surgery is a technique where surgeons use fluorescent markers to identify critical structures such as blood vessels, nerves, or tumors during surgical procedures. This helps ensure precise and safe surgical interventions.
4. Diagnostic tests: Fluorescence-based assays are used in various diagnostic tests to detect and quantify specific biomarkers or analytes. These assays can be performed using techniques such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), or flow cytometry.

In summary, fluorescence is a physical process where a substance absorbs and emits light at different wavelengths. In the medical field, this phenomenon is harnessed for various applications such as in-vivo imaging, microscopy, surgical guidance, and diagnostic tests.

Eye protective devices are specialized equipment designed to protect the eyes from various hazards and injuries. They include items such as safety glasses, goggles, face shields, welding helmets, and full-face respirators. These devices are engineered to provide a barrier between the eyes and potential dangers like chemical splashes, impact particles, radiation, and other environmental hazards.

Safety glasses are designed to protect against flying debris, dust, and other airborne particles. They typically have side shields to prevent objects from entering the eye from the sides. Goggles offer a higher level of protection than safety glasses as they form a protective seal around the eyes, preventing liquids and fine particles from reaching the eyes.

Face shields and welding helmets are used in industrial settings to protect against radiation, sparks, and molten metal during welding or cutting operations. Full-face respirators are used in environments with harmful airborne particles or gases, providing protection for both the eyes and the respiratory system.

It is essential to choose the appropriate eye protective device based on the specific hazard present to ensure adequate protection.

Infrared rays are not typically considered in the context of medical definitions. They are a type of electromagnetic radiation with longer wavelengths than those of visible light, ranging from 700 nanometers to 1 millimeter. In the field of medicine, infrared radiation is sometimes used in therapeutic settings for its heat properties, such as in infrared saunas or infrared therapy devices. However, infrared rays themselves are not a medical condition or diagnosis.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

A rod cell outer segment is a specialized structure in the retina of the eye that is responsible for photoreception, or the conversion of light into electrical signals. Rod cells are one of the two types of photoreceptor cells in the retina, with the other type being cone cells. Rod cells are more sensitive to light than cone cells and are responsible for low-light vision and peripheral vision.

The outer segment of a rod cell is a long, thin structure that contains stacks of discs filled with the visual pigment rhodopsin. When light hits the rhodopsin molecules in the discs, it causes a chemical reaction that leads to the activation of a signaling pathway within the rod cell. This ultimately results in the generation of an electrical signal that is transmitted to the brain via the optic nerve.

The outer segment of a rod cell is constantly being regenerated and broken down through a process called shedding and renewal. The tips of the outer segments are shed and phagocytosed by cells called retinal pigment epithelial (RPE) cells, which help to maintain the health and function of the rod cells.

Smoking is not a medical condition, but it's a significant health risk behavior. Here is the definition from a public health perspective:

Smoking is the act of inhaling and exhaling the smoke of burning tobacco that is commonly consumed through cigarettes, pipes, and cigars. The smoke contains over 7,000 chemicals, including nicotine, tar, carbon monoxide, and numerous toxic and carcinogenic substances. These toxins contribute to a wide range of diseases and health conditions, such as lung cancer, heart disease, stroke, chronic obstructive pulmonary disease (COPD), and various other cancers, as well as adverse reproductive outcomes and negative impacts on the developing fetus during pregnancy. Smoking is highly addictive due to the nicotine content, which makes quitting smoking a significant challenge for many individuals.

Extracellular matrix (ECM) proteins are a group of structural and functional molecules that provide support, organization, and regulation to the cells in tissues and organs. The ECM is composed of a complex network of proteins, glycoproteins, and carbohydrates that are secreted by the cells and deposited outside of them.

ECM proteins can be classified into several categories based on their structure and function, including:

1. Collagens: These are the most abundant ECM proteins and provide strength and stability to tissues. They form fibrils that can withstand high tensile forces.
2. Proteoglycans: These are complex molecules made up of a core protein and one or more glycosaminoglycan (GAG) chains. The GAG chains attract water, making proteoglycans important for maintaining tissue hydration and resilience.
3. Elastin: This is an elastic protein that allows tissues to stretch and recoil, such as in the lungs and blood vessels.
4. Fibronectins: These are large glycoproteins that bind to cells and ECM components, providing adhesion, migration, and signaling functions.
5. Laminins: These are large proteins found in basement membranes, which provide structural support for epithelial and endothelial cells.
6. Tenascins: These are large glycoproteins that modulate cell adhesion and migration, and regulate ECM assembly and remodeling.

Together, these ECM proteins create a microenvironment that influences cell behavior, differentiation, and function. Dysregulation of ECM proteins has been implicated in various diseases, including fibrosis, cancer, and degenerative disorders.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Paraneoplastic cerebellar degeneration (PCD) is a rare disorder characterized by progressive damage to the cerebellum, the part of the brain responsible for coordinating muscle movements. It is considered a paraneoplastic syndrome, which means it is caused by an abnormal immune system response to a cancerous tumor (neoplasm) located elsewhere in the body.

In PCD, antibodies produced by the immune system to fight the tumor mistakenly attack proteins in the cerebellum that are similar to those found in the tumor. This leads to inflammation and degeneration of the Purkinje cells, a type of neuron critical for maintaining balance and coordinating movements.

PCD can present with symptoms such as unsteady gait, loss of coordination, slurred speech, nystagmus (involuntary eye movement), and tremors. These symptoms often develop rapidly, over the course of days to weeks, and may progress even after the tumor has been removed or treated.

PCD is associated with several types of cancers, including small cell lung cancer, breast cancer, ovarian cancer, Hodgkin's lymphoma, and others. Early diagnosis and treatment of the underlying cancer are essential to slowing down the progression of PCD and improving outcomes.

... , also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in ... macular degeneration may be asymptomatic or notice a gradual loss of central vision, whereas those with exudative (wet) macular ... Macular degeneration typically occurs in older people, and is caused by damage to the macula of the retina. Genetic factors and ... Age-related macular degeneration is a main cause of central blindness among the working-aged population worldwide. As of 2020, ...
Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431 (2006). Russell, Peter. Macular ... Stem cell therapy for macular degeneration is the use of stem cells to heal, replace dead or damaged cells of the macula in the ... Macular Degeneration: Stem Cells Restore Sight in Small Study - Medscape - Mar 21, 2018. Chen FK, Uppal GS, MacLaren RE, Coffey ... The retinal sheet was transplanted into a female patient in her 70s with age related macular degeneration (AMD), an eye ...
... histology (OCT) Macular degeneration Macular edema Macular pucker Cherry-red spot Macular hypoplasia Photic retinopathy ... A formulation of 10 mg lutein and 2 mg zeaxanthin has been shown to reduce the risk of age-related macular degeneration ... The progressive destruction of the macula is a disease known as macular degeneration and can sometimes lead to the creation of ... "Macular Degeneration". The Lecturio Medical Concept Library. 6 October 2020. Retrieved 9 August 2021. Helseth, Erek. "Posterior ...
Macular Degeneration Research Program, currently funding 58 research projects. The program started in 1999 and has funded ... "Macular Degeneration Research , BrightFocus Foundation". www.brightfocus.org. Retrieved 2022-12-20. "National Glaucoma Research ... BrightFocus funds research in an effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma, and ... Through its research programs - Alzheimer's Disease Research, National Glaucoma Research, and Macular Degeneration Research - ...
Issues and decay of sensory neurons associated with vision lead to disorders such as: Macular degeneration - degeneration of ... doi:10.1007/BF00198171 de Jong, Paulus T.V.M. (2006-10-05). "Age-Related Macular Degeneration". New England Journal of Medicine ...
"Macular Degeneration, New Zealand". Archived from the original on 16 November 2013. Retrieved 16 November 2013. "Coaching ...
As in macular degeneration, central sight is affected. Atrophy leads to the loss of two or more lines of the Snellen chart. ... Macular degeneration Kumar, Atul; Chawla, Rohan; Kumawat, Devesh; Pillay, Ganesh (2017). "Insight into high myopia and the ... The Fuchs spot (also known as Förster-Fuchs' Spot) is a degeneration of the macula in cases of high myopia. It is named after ... "Pathologic myopia (myopic degeneration) - EyeWiki". eyewiki.aao.org. (Articles with short description, Short description ...
"Macular Degeneration types and risk factors". Archived from the original on 2010-01-10. Retrieved 2010-01-26. Wedl C. Grundzüge ... "Age-Related Macular Degeneration". National Eye Institute. March 2008. Archived from the original on 2008-05-12. Retrieved 2008 ... Hard drusen' may coalesce into 'soft drusen' which is a manifestation of macular degeneration. Around 1850, three authors, Carl ... the presence of larger and more numerous drusen in the macula is a common early sign of age-related macular degeneration (AMD ...
Macular degeneration causes vision loss and increases with age, affecting nearly 12% of those above the age of 80. This ... Mehta S (September 2015). "Age-Related Macular Degeneration". Primary Care. 42 (3): 377-91. doi:10.1016/j.pop.2015.05.009. PMID ... degeneration is caused by systemic changes in the circulation of waste products and by growth of abnormal vessels around the ...
"Treatment of Macular Degeneration." United States Patent Application, US 20040180090. (CS1 location test, Articles with short ...
Alfaro, D. Virgil; Kerrison, John B. (4 September 2014). Age-Related Macular Degeneration. Wolters Kluwer Health. pp. 36-7. ... Alfaro, D. Virgil (2006). Age-related Macular Degeneration: A Comprehensive Textbook. Lippincott Williams & Wilkins. p. 3. ISBN ... The term is familiar in the general public through the widespread macular degeneration (AMD) at older age, where central vision ... movement in music reading Fovea Perimetry Visual field Visual perception Tunnel vision Binocular vision Macular degeneration ...
Rubin, Brian (2003-04-01). "Brian Rubin's Macular Degeneration". Internet Archive. Archived from the original on 2003-04-01. ...
"Medication Cautions in Macular Degeneration". American Macular Degeneration Foundation. Retrieved 30 January 2016. Varma R, ... Age-related macular degeneration may cause macular edema. As individuals age there may be a natural deterioration in the macula ... "What is Age-Related Macular Degeneration?". American Academy of Ophthalmology. Retrieved 30 January 2016. Laly DR (5 March 2014 ... Diabetic macular edema (DME) is similarly caused by leaking macular capillaries. DME is the most common cause of visual loss in ...
Macular degeneration and other diseases affecting the macula cause central field defects. Lesions of the visual pathway cause ... "Age-related Macular Degeneration". 22 October 2013. Archived from the original (JPG) on 2013-10-22. Retrieved 2023-04-03. ... Tubular vision: Since macular fibers are the most resistant to glaucomatous damage, central vision remains unaffected until the ... hemianopsia Paris as seen with right homonymous hemianopsia Tubular vision Central field defect in macular degeneration Visual ...
Oh, J. K.; Tsang, S. H. (2020). "Oh, J. K., & Tsang, S. H. (2020). Stargardt Juvenile Macular Degeneration. New England Journal ... researching how to improve care of people suffering from macular degeneration. "Stephen H. Tsang, MD, PhD". Pathology. 2017-06- ...
Night Vision Symptoms and Progression of Age-related Macular Degeneration in the Complications of Age-related Macular ... Age-related macular degeneration. N Engl J Med. 2000 Feb 17;342(7):483-92. Hariprasad R, Shin DS, Berger JW. An intelligent, ... Age-related macular degeneration. St. Louis: Mosby, 1999 Berger JW. Erbium-YAG laser ablation: the myth of 1-micron penetration ... Ying GS, Maguire MG, Liu C, Antoszyk AN; Complications of Age-related Macular Degeneration Prevention Trial Research Group. ...
... or advance macular degeneration. When central vision is compromised, as in the case of macular scotoma, patients develop an ... "Preferred retinal loci and macular scotoma characteristics in patients with age-related macular degeneration". Can J Ophthalmol ... and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A ... age-related macular degeneration". Ophthalmologica. 225 (3): 155-160. doi:10.1159/000320340. PMID 21150232. S2CID 31494742. ...
"Dry Age-related Macular Degeneration - AMDF". American Macular Degeneration Foundation. Retrieved 2020-12-16. "RG6501 (OpRegen ... "Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration - Full Text View - ... Specifically, Lineage is testing therapies to treat dry age-related macular degeneration, spinal cord injuries, non-small cell ... a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, which is being ...
... which damage macular cone cells and leading to macular degeneration. Heroin is an opioid with a rapid onset of action after ... "Age-Related Macular Degeneration (AMD) , National Eye Institute". www.nei.nih.gov. Archived from the original on 2023-03-06. ... The use of intranasal poppers is associated with the development of macular degeneration through a poorly known mechanism. This ... This results in retinopathic symptoms such as nyctalopia and macular degeneration. Dhingra D, Kaur S, Ram J (September 2019). " ...
"Age-Related Macular Degeneration Treatment". WebMD. Pilyugina S. "Retinal Physician - Ocular Dietary Supplementation - Food For ...
Musarella MA (May 2001). "Molecular genetics of macular degeneration". Documenta Ophthalmologica. Advances in Ophthalmology. ... Vitelliform macular dystrophy causes a fatty yellow pigment (lipofuscin) to build up in cells underlying the macula. The ... Vitelliform macular dystrophy does not affect side (peripheral) vision or the ability to see at night. Researchers have ... Vitelliform macular dystrophy at NLM Genetics Home Reference Best's disease - eMedicine.com GeneReviews/NCBI/NIH/UW entry on ...
1998). "Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q". Arch. Ophthalmol. ... 2007). "Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD ... Mutations in this gene may be associated with age-related macular degeneration. GRCh38: Ensembl release 89: ENSG00000143341 - ... 1997). "Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration". Science. 277 (5333): 1805-7. doi: ...
"Age-Related Macular Degeneration (AMD)". Retrieved December 11, 2013. "Macular Degeneration Frequently Asked Questions". ... Beatty, S; Boulton, M; Henson, D; Koh, H-H; Murray, I J (1999). "Macular pigment and age related macular degeneration". British ... Eye movement Gaze-contingency paradigm Macular degeneration Foveated imaging "Simple Anatomy of the Retina". Webvision. ... The combined effects of the macular pigment and the distribution of short wavelength cones results in the fovea having a lower ...
Ballif suffered from macular degeneration. She retired from the Welfare Commission in 1974, ending her government employment. ...
The macular degeneration comes on slowly with deterioration of central vision, leading to a loss of reading ability. Those ... "Orphanet: Hypotrichosis with juvenile macular degeneration". www.orpha.net. Retrieved 24 June 2019. "Hypotrichose - juvenile ... Hypotrichosis with juvenile macular dystrophy (HJMD or CDH3) is an extremely rare congenital disease characterized by sparse ... "A Rare Syndrome: Hypotrichosis with Juvenile Macular Dystrophy (HJMD)". Investigative Ophthalmology & Visual Science. 55 (13): ...
Wet macular degeneration should be considered in older people with new distortion of their vision with bleeding in the macula. ... It is caused by many ocular conditions like retinal detachment, glaucoma, macular degeneration, and giant cell arteritis, etc. ... "Facts About Age-Related Macular Degeneration". National Eye Institute. June 2015. Archived from the original on 22 December ...
2007). Age-Related Macular Degeneration (2nd ed.). CRC Press/Taylor & Francis. p. 233. ISBN 978-1-4200-1986-5. "Fox News ...
Age-related macular degeneration (AMD) is a disease that affects the eyes and can lead to vision loss through break down of the ... Zarbin MA (April 2004). "Current concepts in the pathogenesis of age-related macular degeneration". Archives of Ophthalmology. ... "Facts About Age-Related Macular Degeneration , National Eye Institute". nei.nih.gov. Retrieved 2019-08-06. Franceschi C, ... Degeneration can occur in one eye or both and can be classified as either wet (neovascular) or dry (atrophic). Wet AMD commonly ...
Some of which are as follows: Age-Related Macular Degeneration (ARMD): ARMD is a retinal degeneration disease specifically ... "Age-related macular degeneration - EyeWiki". eyewiki.org. Retrieved 2020-01-23. "Bulging Eyes - Symptoms and treatments for ... "Diabetic Macular Edema - EyeWiki". eyewiki.org. Retrieved 2020-01-23. "Glossary of Common Eye & Vision Conditions". www.aoa.org ... Diabetic Macular Edema (DME): is an eye disease specifically related to diabetes, occurring due to fluid build-up in the retina ...
The Dyson Institute continues research on the causes and possible therapies for age related macular degeneration and ultrasound ... "Age-related macular degeneration: Choroidal ischaemia?". British Journal of Ophthalmology. 97 (8): 1020-3. doi:10.1136/ ... Vanderbeek, Brian L; Silverman, Ronald H; Starr, Christopher E (2009). "Bilateral Salzmann-like nodular corneal degeneration ...
Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in ... macular degeneration may be asymptomatic or notice a gradual loss of central vision, whereas those with exudative (wet) macular ... Macular degeneration typically occurs in older people, and is caused by damage to the macula of the retina. Genetic factors and ... Age-related macular degeneration is a main cause of central blindness among the working-aged population worldwide. As of 2020, ...
Take steps to reduce your risk of vision loss - learn about age-related macular degeneration and get a dilated eye exam if you ... Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012). Age-related macular degeneration. The Lancet, 379( ... You can take many steps to reduce your risk of vision loss by learning about age-related macular degeneration (AMD). ... Wu, J., Uchino, M., Sastry, S. M., & Schaumberg, D. A. (2014). Age-related macular degeneration and the incidence of ...
Stargardt macular degeneration: MedlinePlus Genetics (National Library of Medicine) * TRNT1 deficiency: MedlinePlus Genetics ( ... Macular pucker - scar tissue on the macula. *Macular hole - a small break in the macula that usually happens to people over 60 ... Vitelliform macular dystrophy: MedlinePlus Genetics (National Library of Medicine) * Wagner syndrome: MedlinePlus Genetics ( ...
Read on to learn about signs that may indicate macular degeneration. ... What are some possible symptoms of macular degeneration? ... www.macular.org/about-macular-degeneration. *. Age-related ... What is exudative macular degeneration?. Exudative macular degeneration is a progressive eye disease that causes leaky blood ... eye-conditions-and-diseases/age-related-macular-degeneration/nutritional-supplements-age-related-macular-degeneration. ...
Macular degeneration that it is the leading cause of blindness for those aged 55 and older in the United States, affecting more ... Macular degeneration is caused by the deterioration of the central portion of the retina or the macula. The macula is ...
Lutein promotes eye health and can help reduce the risk of macular degeneration. Learn more here about the benefits, sources, ... What is macular degeneration? (n.d.).. https://www.macular.org/about-macular-degeneration/what-is-macular-degeneration. ... Macular degeneration involves the deterioration of the macula at the retinas center. This condition is currently the leading. ... Macular degeneration causes damage to the center of vision, and while some people believe that eye drops may help manage the ...
Neovascular age-related macular degeneration (AMD) is an advanced form of AMD that can cause rapid and severe vision loss. ... Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration-the potential sources and ... Age-related macular degeneration (AMD) is a disease that impacts the central area of the retina in the eye, called the macula. ... How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open. ...
... The widely used and well-tolerated drug commonly used to ... The article is "Levodopa Positively Affects Neovascular Age-Related Macular Degeneration," by Anna G. Figueroa, BS, Brennan M. ... Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with ... Collectively, all macular segmentation lines revealed a 92 percent total retinal fluid decrease at 3 months (Credit: The ...
There are two kinds of age-related macular degeneration: wet and dry. Dry AMD, which is more common, is when the macula ... What is macular degeneration? (n.d.).. https://www.macular.org/about-macular-degeneration/what-is-macular-degeneration. ... Is Macular Degeneration Hereditary?. Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. ... What Test Can Help Diagnose Macular Degeneration?. Macular degeneration is a condition that needs to be diagnosed in-person by ...
... Trans Am Ophthalmol Soc. 2000:98:109-15; discussion 115-7. ... Purpose: While most observers agree that age-related macular degeneration (AMD) is much more common in white persons than in ... Presence or absence of AMD and presence and severity of the various macular lesions were determined by "majority vote" of the ...
... Published: 2016/03/07. Author: Macular Degeneration Association - Contact: 1 ... Cite This Page (APA): Macular Degeneration Association. (2016, March 7). Macular Degeneration - Urgent Supplement Warning. ... Age-related macular degeneration (AMD) is the leading cause of legal blindness in people over 55 in the US.. The MDA cites ... Age-related macular degeneration is expected to affect almost 20 million people by 2020. Because overall life expectancy ...
I have a CCTV at work and at home thanks to the Oregon Commission for the Blind. I have ZoomText with sound at home and at work. I am currently taking mobility training through the commission to become as independent as possible, and I do enjoy talking books. I am also working toward getting a guide dog and learning Braille.. Working ...
... age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people ... Diabetic Macular Edema, Diabetic Retinopathy, Edema, Eye, Eye Disease, Hospital, Inflammation, Macular Degeneration, Macular ... Age-related macular degeneration patient receives investigational eye drops. *Download PDF Copy ... Tags: Age-Related Macular Degeneration, B Cell, Blindness, Blood, Blood Vessel, Blood Vessels, Cell, Cell Death, ...
Age-related macular degeneration (AMD) is a common condition that affects the middle part of your vision. It usually first ... Age-related macular degeneration (AMD). Age-related macular degeneration (AMD) is a common condition that affects the middle ... Find out more about age-related macular degeneration (AMD) on the NHS website ... The Macular Society has more on diet and nutrition for AMD.. Driving. AMD can make it unsafe for you to drive. Ask your ...
... age-related macular degeneration) is a vision loss disease that is the primary cause of blindness and vision loss in Americans ... Eye Diseases Macular Degeneration. What is Macular Degeneration?. Macular degeneration or AMD (age-related macular degeneration ... dry macular degeneration and wet macular degeneration.. Dry Macular Degeneration. Dry, or non-neovascular macular degeneration ... Wet Macular Degeneration. In one out of 10 cases, dry macular degeneration advances to wet macular degeneration. Wet AMD is ...
Age-related macular degeneration (AMD) is a disorder of the macula, the small, central portion of the retina that processes the ... There are two common types of macular degeneration. The more common "dry" form is associated with the aging and thinning of the ...
MORE FROM THE WAIRARAPA TIMES-AGE ...
Types of macular degeneration Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the ... Types of macular degeneration. Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the ... Age-Related Macular Degeneration (AMD)) and Exudative (Wet) Age-Related Macular Degeneration (AMD) What to Read Next on ... and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol ...
Age-related Macular degeneration. Dietary causes of macular degeneration :. polyunsaturated vegetable margarines and cooking ... Dr Paul Beaumont from the Australian macular degeneration foundation is horrified at the rate macular degeneration has ... a blindness called age-related macular degeneration or AMD. Affecting millions, age-related macular degeneration is the second ... Age-related macular degeneration (AMD) involves a number of degenerative changes in the macular region and is leading cause of ...
... is a treatment for wet age-related macular degeneration (wet AMD). It is not used to treat dry AMD. Photodynamic therapy may be ... Photodynamic Therapy for Age-Related Macular Degeneration Photodynamic Therapy for Age-Related Macular Degeneration. *. ... age-related macular degeneration. (wet AMD). It is not used to treat dry AMD. ...
... for the treatment of age-related macular degeneration (AMD) ... for the treatment of age-related macular degeneration. ... Evidence-based recommendations on ranibizumab (Lucentis) and pegaptanib (Macugen) for treating wet age-related macular oedema ...
In age-related macular degeneration, the nerve cells are destroyed in the macula - the point of sharpest vision on the retina. ... The initial symptoms of macular degeneration. The first sign of age-related macular degeneration can be when straight lines ... In age-related macular degeneration, the nerve cells are destroyed in the macula - the point of sharpest vision on the retina. ... "Dry" age-related macular degeneration (AMD) is the most common form of the disease. It only progresses slowly, so that the ...
Contact MDFA for free information and advice on macular disease. ... Vietnamese language trifold brochure on age-related macular ... About macular disease *About macular disease. *Age-related macular degeneration *AMD overview ...
Browse Macular degeneration news, research and analysis from The Conversation ... Macular degeneration affects the part of the eye that allows you to see fine detail. Age-related macular degeneration is the ... Artículos sobre Macular degeneration. Mostrando todos artículos. Shutterstock 1 febrero 2023 Macular diseases cause blindness ... Macular degeneration can result in blurred or no vision in the center of the visual field. (Shutterstock) 1 junio 2021 Macular ...
Perhaps you have already suffered some kind of vision loss due to age related macular degeneration (AMD). Typically some of the ... Vision Loss Due To Age Related Macular Degeneration. Vision Loss Due To Age Related Macular Degeneration. Posted on Feb.17, ... Perhaps you have already suffered some kind of vision loss due to age related macular degeneration (AMD). Typically some of the ... While macular diseases are the result of changes in the back of the eye, the retina, cataract formation is the result of ...
Atrophic age-related macular degeneration (AMD) is the most common form of AMD accounting for 90% of patients. During atrophic ... Atrophic age-related macular degeneration (AMD) is the most common form of AMD accounting for 90% of patients. During atrophic ... Age-related macular degeneration (AMD) is a progressive disease of the retina that is the leading form of blindness in ... Atrophic age-related macular degeneration (AMD) is the most common form of AMD accounting for 90% of patients. During atrophic ...
British Journal of Ophthalmologys topic collection on the subject of macular degeneration ... Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence ...
... induced age-related macular degeneration (AMD) development and the associated mechanism. Expression of SIRT1/SOX9/LCN2 in the ... S. Mehta, "Age-related macular degeneration," Age-Related Macular Degeneration. Prim Care, vol. 42, pp. 377-391, 2015. ... J. Li, J. He, X. Zhang, J. Li, P. Zhao, and P. Fei, "TSP1 ameliorates age-related macular degeneration by regulating the STAT3- ... P. Mitchell, G. Liew, B. Gopinath, and T. Y. Wong, "Age-related macular degeneration," Lancet, vol. 392, no. 10153, pp. 1147- ...
A better understanding of rods and cones may help researchers treat retinitis pigmentosa (RP) and macular degeneration, two ... Clues To Development Of Eyes Light-Sensitive Cells Found; Study Has Implications For Understanding Macular Degeneration And ... This knowledge holds promise for developing treatments for macular degeneration, a disease in which photoreceptors in the ... "Clues To Development Of Eyes Light-Sensitive Cells Found; Study Has Implications For Understanding Macular Degeneration And ...
What is age-related macular degeneration, the most common cause of severely reduced vision. ✅ Specialised treatment at ... What is the most common type of age-related macular degeneration? The most common age-related macular degeneration is dry or ... What is age-related macular degeneration?. Age-related macular degeneration (AMD) is a degenerative disease of the macula that ... How does a person with age-related macular degeneration see? When a person suffers from this pathology, they may have symptoms ...
  • There are two main types of macular degeneration: dry macular degeneration and wet macular degeneration. (lensshopper.com)
  • There are two common types of macular degeneration. (uclahealth.org)
  • Physicians have traditionally recognized 2 types of macular degeneration: dry and wet. (medscape.com)
  • Age-related macular degeneration is a main cause of central blindness among the working-aged population worldwide. (wikipedia.org)
  • Trouble discerning colors, specifically dark ones from dark ones and light ones from light ones A loss in contrast sensitivity Formed visual hallucinations and flashing lights have also been associated with severe visual loss secondary to wet AMD Macular degeneration by itself will not lead to total blindness. (wikipedia.org)
  • Macular degeneration that it is the leading cause of blindness for those aged 55 and older in the United States, affecting more than 10 million Americans and is currently incurable. (ferris.edu)
  • The Macular Degeneration Association, a nonprofit dedicated to preventing blindness, today issued an urgent warning to patients suffering from a form of the disease known as "intermediate dry age-related macular degeneration. (disabled-world.com)
  • Age-related macular degeneration (AMD) is the leading cause of legal blindness in people over 55 in the US. (disabled-world.com)
  • An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States. (news-medical.net)
  • There is an eye condition spreading rapidly throughout Western society like an epidemic - a blindness called age-related macular degeneration or AMD. (second-opinions.co.uk)
  • Affecting millions, age-related macular degeneration is the second leading cause of blindness in humans. (second-opinions.co.uk)
  • Age-related macular degeneration (AMD) involves a number of degenerative changes in the macular region and is leading cause of blindness particularly in people with diabetes. (second-opinions.co.uk)
  • The major reason for blindness in Australia 30 years ago was the retinopathy which accompanies diabetes and it was rare to find macular degeneration. (second-opinions.co.uk)
  • However, an estimated 196 million people globally live with age-related macular degeneration, 10.4 million of whom (5,3%) have moderate or severe distance vision impairment or blindness from more severe forms of the condition. (bayer.com)
  • This substance can prevent blindness in people with wet age-related macular degeneration (AMD). (bayer.com)
  • Age-related macular degeneration (AMD) is a progressive disease of the retina that is the leading form of blindness in developed countries. (frontiersin.org)
  • Age-related macular degeneration (AMD) is the leading cause of functional blindness in humans older than age 65 in developed countries around the world (American Academy of Ophthalmology, 2001). (ndnr.com)
  • Dr. Svetlana Pilyugina, Los Angeles Retina Specialist, discusses macular degeneration and blindness. (assileye.com)
  • Two major eye diseases and leading causes of blindness-age-related macular degeneration and diabetic retinopathy-can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study. (impactlab.com)
  • Age-related macular degeneration is the most common cause of legal blindness in people age 65 or older and is expected to become an increasingly common and costly health issue as the number of older people in United States increases. (impactlab.com)
  • Macular degeneration is a major cause of blindness and anything that will prevent it or slow its development down is of interest. (dairyscience.info)
  • Age-related eye diseases such as glaucoma, cataract, diabetic retinopathy, and age-related macular degeneration, are the leading causes of visual impairment and blindness in North America. (powershow.com)
  • The American Macular Degeneration Foundation has created a video depicting what someone with AMD sees . (healthline.com)
  • Dry AMD is also more common than wet AMD: About 85 to 90% of age-related macular degeneration diagnoses are dry AMD, according to the American Macular Degeneration Foundation . (healthline.com)
  • Example: Yes, I would like to receive emails from American Macular Degeneration Foundation. (macular.org)
  • In the wet, or exudative, form of age-related macular degeneration (AMD or ARMD), pathologic choroidal neovascular membranes (CNVM) develop under the retina. (medscape.com)
  • Other signs and symptoms of macular degeneration include: Distorted vision in the form of metamorphopsia, in which a grid of straight lines appears wavy and parts of the grid may appear blank: Patients often first notice this when looking at things like miniblinds in their home or telephone poles while driving. (wikipedia.org)
  • In addition, people with dry macular degeneration often do not experience any symptoms but can experience gradual onset of blurry vision in one or both eyes. (wikipedia.org)
  • People with wet macular degeneration may experience acute onset of visual symptoms. (wikipedia.org)
  • The possible symptoms of macular degeneration typically depend on its stage. (medicalnewstoday.com)
  • Lutein, a type of compound known as a carotenoid, may play a role in preventing or reducing the symptoms of macular degeneration. (medicalnewstoday.com)
  • What are the symptoms of dry age-related macular degeneration? (healthline.com)
  • You'll experience no symptoms, but a doctor will be able to see the macular degeneration during an eye exam. (healthline.com)
  • At the intermediate stage, you might experience mild symptoms of macular degeneration. (healthline.com)
  • This mp3 file uses sound to energetically restore the imbalances at the source of Macular Degeneration relieving symptoms and across time allows for the restoration of normal functioning. (the-tree-of-life.com)
  • Macular degeneration typically occurs in older people, and is caused by damage to the macula of the retina. (wikipedia.org)
  • Even though the macula provides such a small fraction of the visual field, almost half of the visual cortex is devoted to processing macular information. (wikipedia.org)
  • Age-related macular degeneration (AMD) is a progressive eye condition that damages the macula in the eye. (medicalnewstoday.com)
  • Macular degeneration is caused by the deterioration of the central portion of the retina or the macula. (ferris.edu)
  • Macular degeneration involves the deterioration of the macula at the retina's center. (medicalnewstoday.com)
  • Age-related macular degeneration (AMD) is a disease that impacts the central area of the retina in the eye, called the macula. (roche.com)
  • Macular degeneration occurs when a part of the retina called the macula degrades. (lensshopper.com)
  • Dry, or non-neovascular macular degeneration occurs when aging macular issues begin to thin out, or pigment begins to build up in the macula. (lensshopper.com)
  • Age-related macular degeneration (AMD) is a disorder of the macula, the small, central portion of the retina that processes the sharp, "straight ahead" vision needed for reading, driving a car or recognizing faces. (uclahealth.org)
  • In age-related macular degeneration, the nerve cells are destroyed in the macula - the point of sharpest vision on the retina. (bayer.com)
  • If untreated, chronic macular edema can lead to irreversible damage of the macula and permanent vision loss. (tmcnet.com)
  • AMD is characterized by progressive degeneration of the macula, the central part of the retina, leading to central vision loss. (delveinsight.com)
  • When Macula or central portion of your eye deteriorates, the condition is called Macular degeneration. (powershow.com)
  • Age-related macular degeneration (AMD) is an eye disease that causes the macula to lose its normal structure (called degeneration). (msdmanuals.com)
  • Best disease, also termed vitelliform macular dystrophy, is typically an autosomal dominant disorder, which classically presents in childhood with the striking appearance of a yellow or orange yolklike lesion in the macula. (medscape.com)
  • AREDS supplements have been shown to benefit the average patient with moderate macular degeneration, but our research suggests that this average benefit is the result of significantly different individual responses," says Carl Awh, MD, a retina specialist from Nashville, Tenn. (disabled-world.com)
  • While macular diseases are the result of changes in the back of the eye, the retina, cataract formation is the result of changes in the lens which is in the front of the eye. (enhancedvision.com)
  • This knowledge holds promise for developing treatments for macular degeneration, a disease in which photoreceptors in the macular area of the retina die off. (sciencedaily.com)
  • AMD affects the macular, center portion of the retina, that is responsible for central vision and color perception. (tmcnet.com)
  • Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. (cehjournal.org)
  • Macular Thickening - Acceptable synonyms for "macular thickening" include: intraretinal thickening, serous detachment of the retina, pigment epithelial detachment or macular edema. (mdinteractive.com)
  • The researchers also noted that consuming green vegetables may help prevent macular degeneration. (medicalnewstoday.com)
  • Recent research has shown that both lutein and zeaxanthin work to prevent macular degeneration. (medicalnewstoday.com)
  • Alessandro Iannaccone, MD, MS, FARVO is Professor of Ophthalmology and Director of the Center for Retinal Degenerations and Ophthalmic Genetic Diseases, which was established in 2016. (duke.edu)
  • Prior to joining Duke University, Dr. Iannaccone was an Associate Professor of Ophthalmology at the Hamilton Eye Institute in Memphis, TN, where he served as the founding Director of the Retinal Degenerations & Ophthalmic Genetics Service and the Lions' Visual Function Diagnostic Lab since 1997. (duke.edu)
  • February 27, 2009 - Serum cystatin C level and chronic kidney disease may have a link to incidence of age-related macular degeneration (AMD) that is independent of smoking and other risk factors, according to a population-based cohort study reported in the February issue of the Archives of Ophthalmology . (medscape.com)
  • Spectral domain − optical coherence tomography images of the same macular segmentation line at baseline and monthly follow-up visits in a patient naïve to intravitreal anti-vascular endothelial growth factor (VEGF) therapy. (elsevier.com)
  • On occasions, we undertake a fluoroscein angiography (the injection of an endovenous contrast dye that helps us to study the location and size of the neovascular membrane in greater detail) to confirm the diagnosis and an optical coherence tomography (a scan of the macular to that shows indirect signs of the disease's activity) to help us during follow-up. (barraquer.com)
  • The "wet" form of macular degeneration (about 10 to 15 percent of all AMD cases) causes much more serious restrictions of vision. (bayer.com)
  • Nutrient approaches will be discussed, but it is important to remember that the eye physician community often recommends some form of macular supplement with at least vitamins C, E and beta-carotene with the minerals zinc and copper. (ndnr.com)
  • We're delighted to announce funding for this project, and what better time than at the start of Macular Week 2019. (fightforsight.org.uk)
  • The age-related macular degeneration market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted 7MM age-related macular degeneration market size from 2019 to 2032. (delveinsight.com)
  • Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. (wikipedia.org)
  • Importance Age-related macular degeneration (ARMD) therapies aflibercept and ranibizumab are among the highest- cost Medicare Part B drugs , even though off-label use of lower- cost bevacizumab is clinically noninferior. (bvsalud.org)
  • Other complicating conditions may lead to such an acute condition (severe stroke or trauma, untreated glaucoma, etc.), but few macular degeneration patients experience total visual loss. (wikipedia.org)
  • Participants 40 years and older were eligible for a new set of questions on eye diseases, including glaucoma and age-related macular degeneration. (cdc.gov)
  • What is the most common type of age-related macular degeneration? (barraquer.com)
  • Our hope is that our work could lead to an entirely new, exciting and beneficial treatment for patients with this type of age-related macular degeneration where there are few current options. (fightforsight.org.uk)
  • Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration-the potential sources and molecular cues for their recruitment and activation. (roche.com)
  • Bone RA, Landrum JT, Tarsis SL: Preliminary identification of the human macular pigment. (karger.com)
  • Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis. (duke.edu)
  • BACKGROUND: We investigated sera from elderly subjects with and without age-related macular degeneration (AMD) for presence of autoantibodies (AAbs) against human macular antigens and characterized their identity. (duke.edu)
  • Genentech, Inc., South San Francisco, CA, USA) is a vascular endothelial growth factor inhibitor that is approved by the US Food and Drug Administration as an antineoplastic agent but is commonly used off-label to treat retinal disorders, including age-related macular degeneration ( 1 , 2 ). (cdc.gov)
  • One of the first signs of dry macular degeneration is when drusen, yellowish deposits from deteriorating tissue, appears on the eye, accompanied with gradual loss of central vision. (lensshopper.com)
  • TG100801 is also designed to reduce inflammation (including edema), a common symptom of AMD, and other back of the eye diseases, including diabetic macular edema and diabetic retinopathy. (news-medical.net)
  • Researchers at the Massachusetts Eye and Ear Infirmary carried out a study of 349 individuals aged 55 to 80 with age-related macular degeneration (AMD), and compared their diet to a control group with eye diseases other than AMD. (second-opinions.co.uk)
  • With macular diseases, cone cells deteriorate - there are less of them and the ones that are left are not functioning like healthy cone cells. (enhancedvision.com)
  • A better understanding of rods and cones may help researchers treat retinitis pigmentosa (RP) and macular degeneration, two major eye diseases that involve loss of photoreceptors, resulting in slow but progressive vision loss. (sciencedaily.com)
  • Damage from both diseases was prevented and even reversed when the protein, Robo4, was activated in mice models that simulate age-related macular degeneration (AMD) and diabetic retinopathy, according to Dean Y. Li, M.D., Ph.D., senior author of the study published March 16 in Nature Medicine online. (impactlab.com)
  • Given that vascular eye diseases, such as age related macular degeneration and diabetic retinopathy, are the number one cause of vision loss in the United States, the identification of new signaling pathways that prevent abnormal vessel growth and leakage in the eye represents a major scientific advancement," said Chin. (impactlab.com)
  • But when the body grows new blood vessels at the wrong time or place, these blood vessels are often unstable and weak, which causes them to leak and potentially lead to diseases such as macular degeneration and diabetic retinopathy. (impactlab.com)
  • Complement factor I (FI) is a central inhibitor of the complement system, and impaired FI function increases complement activation, contributing to diseases such as age-related macular degeneration (AMD) and atypical hemolytic uremic syndrome (aHUS). (lu.se)
  • One of these diseases is age-related macular degeneration (AMD), a leading cause of visual impairment in the developed world. (medscape.com)
  • COSTA MESA, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun a Phase 1 trial and completed dosing the first cohort of patients diagnosed with wet age-related macular degeneration (wAMD), and/or diabetic macular edema (DME). (tmcnet.com)
  • Diabetic macular edema is manifested as retinal thickening and swelling caused by accumulation of intraretinal fluid usually due to blood sugar levels being consistently high. (tmcnet.com)
  • Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision. (elsevier.com)
  • Macular Degeneration Association Issues Urgent Supplement Warning for Patients - Genetic Swab Test Can Help Doctors Determine if AREDS Supplements Helpful or Harmful. (disabled-world.com)
  • His review suggests that all of the AREDS genetic data as published demonstrates a detrimental effect in at least 13 percent of patients with macular degeneration. (disabled-world.com)
  • Atrophic age-related macular degeneration (AMD) is the most common form of AMD accounting for 90% of patients. (frontiersin.org)
  • The OCT images showed the absence of a foveal pit and destruction of the outer retinal layers in the macular area in all patients. (nih.gov)
  • The hypothesis that oral supplementation of the epilutein/lutein combination could augment the macular pigment optical density (MPOD) in patients with age-related macular degeneration (AMD) was tested. (karger.com)
  • Do all Macular Degeneration Patients Go Blind? (assileye.com)
  • This Macular Week, Fight for Sight is pleased to announce funding for scientists at Queen's University Belfast who hope to boost the capacity for damaged tiny blood vessels in the back of the eye to repair themselves to prevent or slow down sight loss for patients with age-related macular degeneration. (fightforsight.org.uk)
  • Pixium, a Paris based company has developed a system that may enhance vision by stimulating degenerated photoreceptor cells in patients with advanced dry macular degeneration. (webrn-maculardegeneration.com)
  • It is anticipated that Merit-based Incentive Payment System (MIPS) eligible clinicians who provide the primary management of patients with age-related macular degeneration (in either one or both eyes) will submit this measure. (mdinteractive.com)
  • ROCHESTER, Minn. - The primary treatment for wet macular degeneration, a chronic eye condition that causes vision loss, is effective even if patients have macular traction problems, a Mayo Clinic study shows. (mayoclinic.org)
  • Due to the aging population, an increasing number of patients are being treated for age-related macular degeneration (AMD) , an eye condition in which abnormal blood vessels develop and leak into the eye. (mayoclinic.org)
  • During March 6-8, 2013, four patients with age-related macular degeneration received a diagnosis of acute endophthalmitis after receiving intravitreal bevacizumab injections on March 4, 2013, at a retinal specialty clinic (clinic A) in Georgia. (cdc.gov)
  • Contrast sensitivity in patients with macular degeneration. (bvsalud.org)
  • Macular degeneration is considered age-related when it occurs in people over 55 years of age. (healthline.com)
  • This formula eliminates the energetic field within which Macular Degeneration occurs and returns the body to normal functioning. (the-tree-of-life.com)
  • To investigate the functional implications of macular soft drusen regression in AMD eyes. (bmj.com)
  • Macular soft drusen may fade or disappear without detectable ophthalmoscopic, FA or psychophysical signs of local dysfunction. (bmj.com)
  • Another treatment, called photodynamic therapy (PDT), works on wet macular degeneration sufferers by injecting a drug (Visudyne) into the arm. (lensshopper.com)
  • Photodynamic therapy (PDT) is a treatment for wet age-related macular degeneration (wet AMD). (cigna.com)
  • AMD is an eye disease that leads to macular damage and subsequent loss of central vision. (medicalnewstoday.com)
  • Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. (roche.com)
  • Macular degeneration or AMD (age-related macular degeneration) is a vision loss disease that is the primary cause of vision loss in Americans who are 65 and over. (lensshopper.com)
  • Dry" age-related macular degeneration (AMD) is the most common form of the disease. (bayer.com)
  • Adult vitelliform macular dystrophy resembles Best disease, but it can be differentiated by its later age of onset, smaller lesion, and normal electro-oculogram testing. (medscape.com)
  • A 2022 study examined almost 4,000 people over 10 years and found that regular lutein and zeaxanthin supplements helped reduce the progression of late-stage macular degeneration. (medicalnewstoday.com)
  • Oxidative damage to the retinal pigment epithelium (RPE) and photoreceptors, which is exacerbated by low-quantity or dysfunctional macular pigments (lutein and zeaxanthin). (ndnr.com)
  • Two families with Stickler syndrome with the p.R565C mutation showed more severe foveal hypoplasia, macular degeneration, and extensive retinal degeneration. (nih.gov)
  • DelveInsight's 'Age-related Macular Degeneration (AMD)-Market Insights, Epidemiology, and Market Forecast-2032' report deliver an in-depth understanding of the Age-related Macular Degeneration, historical and forecasted epidemiology as well as the Age-related Macular Degeneration market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. (delveinsight.com)
  • You can take many steps to reduce your risk of vision loss by learning about age-related macular degeneration (AMD). (cdc.gov)
  • Age-related macular degeneration (AMD) is a common condition that affects the middle part of your vision. (nidirect.gov.uk)
  • A drug called Lucentis has showed some promise in improving the vision of macular degeneration sufferers. (lensshopper.com)
  • Two-thirds of those who lose their vision are blind due to age-related macular degeneration. (second-opinions.co.uk)
  • Perhaps you have already suffered some kind of vision loss due to age related macular degeneration (AMD). (enhancedvision.com)
  • At the end of this post, you'll hear from Don Biondich, who has ridden his 'hog' on six continents and was a certified pilot of nearly every kind of aircraft class… that is before his vision was ravaged by Macular Degeneration. (rechargebiomedical.com)
  • It is not due to my macular degeneration but rather a loss of vision acuity. (rechargebiomedical.com)
  • With adaptation and the right supports, people can continue to thrive despite vision loss from age-related macular degeneration. (macular.org)
  • Vision loss due to macular degeneration is linked to cognitive decline. (macular.org)
  • We once heard from a woman with macular degeneration that one of the surprising little frustrations of vision loss was how difficult it is to see to plug things into outlets. (macular.org)
  • The results showed that these individuals experienced an increase in the density of macular pigments. (medicalnewstoday.com)
  • There are no proven successful treatments for dry macular degeneration other than nutritional supplements. (lensshopper.com)
  • Current treatments are effective in slowing down AMD, but they do not reverse the degeneration that has already occurred. (brightfocus.org)
  • Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists. (bvsalud.org)
  • Choroidal neovascularization (CNV), as the pathological process of the invasion of abnormal blood vessels into the subretinal space of the mammalian eye, is known as a feature of the age-related macular degeneration (AMD) [ 1 ]. (hindawi.com)
  • Presence or absence of AMD and presence and severity of the various macular lesions were determined by "majority vote" of the readers. (nih.gov)
  • Severity of Macular Degeneration - Early, intermediate and advanced. (mdinteractive.com)
  • A documented complete macular examination is a necessary prerequisite to determine the presence and severity of AMD, so that a decision can be made as to the benefits of prescribing antioxidant vitamins. (mdinteractive.com)
  • Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population. (roche.com)
  • The prevalence of age-related macular degeneration is increasing in Asia due to increase in life expectancy and rising incidents of diabetes among the younger population. (powershow.com)
  • Together, these results suggest that daily lutein intake can improve eye health for people with macular degeneration. (medicalnewstoday.com)
  • Thanks to Sandra for a series of Emails about recommending good food sources of lutein and whether there is any evidence to suggest that increasing lutein intake can help ward off macular degeneration or slow it down if it has developed. (dairyscience.info)
  • Twilight - Losing Sight, Gaining Insight by Henry Grunwald is one of the few memoirs on the market that is specific to losing sight from age-related macular degeneration. (macular.org)
  • Macular Degeneration Prevention and Risk Factors. (roche.com)
  • Available from: http://www.brightfocus.org/macular/prevention-and-risk-factors. (roche.com)
  • What is the Treatment for Macular Degeneraton? (lensshopper.com)
  • More and more medicines that inhibit a specific growth factor known as VEGF (vascular endothelial growth factor) are used today in the treatment of wet age-related macular degeneration. (bayer.com)
  • In 2013, Bayer's anti-VEGF therapy was first approved for the treatment of wet age-related macular degeneration (wet AMD) in Canada. (bayer.com)
  • Last week, the FDA approved an embryonic stem cell trial for treatment of Macular Degeneration, which is very promising since there is currently no adequate treatment for the condition which is known to affect 2% of those over 50, and 30% of people over 75. (rechargebiomedical.com)
  • A macular degeneration treatment breakthrough is making headway using a wireless retinal implant. (webrn-maculardegeneration.com)
  • The Report also covers current age-related macular degeneration treatment practice, market drivers, market barriers, SWOT analysis, reimbursement, market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. (delveinsight.com)
  • In one review , researchers analyzed the results of studies on individuals with macular degeneration who consumed 10 or 20 milligrams (mg) of lutein daily for at least 6 months. (medicalnewstoday.com)
  • In another small study , researchers followed 39 people with macular degeneration who took 20-mg lutein supplements daily for 6 months. (medicalnewstoday.com)
  • Much lower, than the 10 mg recommended by some researchers working on macular health. (dairyscience.info)
  • Evidence-based recommendations on ranibizumab (Lucentis) and pegaptanib (Macugen) for treating wet age-related macular oedema in adults. (nice.org.uk)
  • Dr Paul Beaumont from the Australian macular degeneration foundation is horrified at the rate macular degeneration has multiplied. (second-opinions.co.uk)
  • retinal fluid completely resolved at the same macular segmentation line at month 2, and fluid remained stable up to month 3 without anti-VEGF injections. (elsevier.com)
  • Findings showed that while eyes with some kind of macular traction required more injections, they still showed improvement (best corrected visual acuity) to similar eyes without VMID. (mayoclinic.org)
  • Age-related macular degeneration is expected to affect almost 20 million people by 2020. (disabled-world.com)
  • People with higher levels of lutein are at a lower risk of developing macular degeneration. (medicalnewstoday.com)
  • In addition, as it is closely linked to ageing, it is estimated that the number of people with macular degeneration could double in the next 20 years due to the increase in the life expectancy of the population. (barraquer.com)
  • Macular Degeneration (AMD) has been identified as a common condition affecting people more than 50 years old. (powershow.com)
  • Degeneration (AMD) develops slowly, affecting people at a later stage. (powershow.com)
  • People with certain lifestyle habits are more prone to Age-Related Macular Degeneration (AMD). (powershow.com)
  • Individuals who have macular degeneration or are at risk of developing it should consider adding kale or other lutein sources to their diet. (medicalnewstoday.com)
  • The Macular Society has more on diet and nutrition for AMD . (nidirect.gov.uk)
  • Food Suggestions for a Macular Degeneration Diet? (webrn-maculardegeneration.com)
  • One common condition is dry age-related macular degeneration (AMD), which affects your central eyesight. (healthline.com)
  • While most observers agree that age-related macular degeneration (AMD) is much more common in white persons than in persons of black African ancestry, the influence of iris color has been more controversial. (nih.gov)
  • The most common age-related macular degeneration is dry or atrophic which affects almost 85% of cases. (barraquer.com)